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ABSTRACT
Substrate Nanotopography and Stiffness Modulation of Cell
Behaviors for Disease Detection and Modeling
Lin Shi

In most living tissue, cells resident in a complex microenvironment where these cells
interact with the extracellular matrix (ECM) and the neighboring cells. The interactions between
cells and ECM could regulate the cell behavior. Similar to in vivo, in vitro models have been
reported that cells have the ability to sense the nanotopography and stiffness of synthetic substrate
and, the variation of substrate nanotopography configuration and stiffness could affect cell
phenotype and function.
The first project focused on applying nanotopography to capture circulating tumor cells
(CTCs) for early cancer detection. CTCs shed from primary tumors, transport through the
bloodstream to distant sites, and cause 90% of cancer deaths. Although different techniques have
been developed to isolate CTCs for cancer detection, diagnosis and treatment, the heterogeneity
of expression of the target antigen and the significant size variance in CTCs limit clinical
applications of antibody- and size-based isolation techniques. Cell adhesion using nanotopography
has been suggested as a promising approach to isolate CTCs independent of surface marker
expression or size of CTCs. However, the influence of nanotopography configuration (geometry
and dimensions) on CTC capture efficiency has not been investigated. This study examined
capture performance of several cancer cell lines of different types, surface marker expression and

metastatic status on nanotopographies of various geometry and dimensions without antibody
conjugation. Compared with flat surfaces and isotropic, discrete nanopillars, anisotropic
nanogratings favored cancer cell adhesion, thus improving the capture efficiency. This study
provides useful information to optimize nanotopography to further enhance CTC capture
efficiency.
The second project focused on understanding the effects of substrate stiffness on fibrogenic
responses of human lung fibroblasts to engineered nanomaterials. Most existing in vitro models
focused on conducting the experiment using the rigid tissue culture polystyrene (TCPS) surfaces,
which were much stiffer than the actual in vivo cell microenvironment. Thus, the behavior and
nanomaterial responsiveness of cells could be largely changed due to the deviation of substrate
stiffness when cultured on TCPS. Therefore, it is of the critical need to create physiologically
relevant tissue models to mimic the in vivo environment by introducing stiffness cue. This study
used the synthesized polyacrylamide (PAAm) hydrogel to represent the normal and fibrotic
conditions of lung tissues to conduct in vitro models. The fibrogenic responses and
mechanosensing of fibroblasts to carbon nanotubes (CNTs) at different stiffness conditions have
been explored. This study provides understanding of the regulatory pathways and mediators of
fibrogenic activities, which will potentially help identify therapeutic targets against fibrosis.
The incorporation of substrate nanotopography and stiffness could be further applied in
three-dimensional culture model as the difference in dimensionality could also substantially
change the cell behavior and function. Cells under in vivo conditions are embedded in multiple
ECM components and experiencing different biophysical stimuli compared to those cultured on
top of the two-dimensional substrate. Moreover, by introducing flow and shear stress into the in
vivo system could largely replicate the in vivo condition, like the ultimate organ-on-a-chip

microfluidic device. This study provides insight on building physiologically relevant in vitro
model for disease detection and modeling and could be future applied in drug development and
disease treatment.
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Chapter 1: Introduction
The nature of in vivo condition
The nature of in vivo environment where cells typically resident in is consist of various
topographical structures and different degrees of stiffness. In the cell microenvironment, the ECM
plays a significant role in regulating the phenotype and function of cells.1 The role of this dynamic
structure is not only to provide solid support surrounding the cells, but also transduce physical
signals to cells, thus regulating cell phenotype and function. The composition of ECM was
identified years ago,1, 2, 3 and the important role of ECM has been more and more realized recently.
The complex network of ECM is formed by a diversity of macromolecules secreted by cells,
including different types of collagen, proteoglycans, glycoproteins, extracellular vesicles and
many other structures, result in serious diversification in ECM structure.1, 4, 5, 6, 7, 8, 9, 10 Tissues that
come from different organs may contain different ECM structure. Such diversity and variation are
a natural selection that would satisfy the different biological related function requirement from
different organ systems. For example, the extracellular components in the alveolar region of the
lung include both noncellular interstitium and basement membranes.11 Most basement membranes
are consist of proteins like type IV collagen, entactin and laminin, as well as proteoglycans.12
However, the constituents of lung interstitium are fibrillar collagens, elastic fibers, and
proteoglycans.11, 13, 14
Typically, the various macromolecules present in ECM often exhibit three-dimensional
nanotopography, as shown in Figure 1-1 (a).15 Furthermore, the differential composition of ECM
structure in different organs results in various stiffness, as shown in Figure 1-1 (b).15 These
biophysical cues, including nanotopographical cue and stiffness cue, are highly organized within
1

the ECM1, where the regulation of ECM allows cells to exhibit different phenotypes and
functions.15

Figure 1-1: The biophysical cues that exist in typical human tissues. (a) Illustration of the threedimensional nanotopographical structures in different human tissues. The enlarged box shows
SEM images of the nanostructures in bone, nerve, skin and alveolar interstitium. (b) Different
human tissues fall into a wide range of stiffness from 10 Pa to over 1 GPa (Adapted with
permission from Ref. [15])
Growing and compelling evidence has shown that other than the chemical cues that can
provide modulations to cells, the mechanical properties of these physical cues (topography and
rigidity) plays significant roles in directing the cell fate, cell elongation, motility, migration and
differentiation, thus have an impact on various ongoing process in vivo.16,

17, 18, 19, 20

As for

topography cue, for example, the nervous system is composed of a complex network of threedimensional topographical structures, which covers a broad range of size for each component.16 In
2

vivo studies have suggested that some of the topographical features guide cell migration during the
development of cerebral cortex21 and cerebellum22. However, since there are constant alterations
in chemical composition that intrinsically present in the actual in vivo condition, it is difficult to
interpret the cell behavior by topographical guidance exclusively. An increasing number of in vitro
models have been established using engineered substrates to understand the topography regulated
cell behaviors. Evidence has shown that roughly aligned collagen fibrils can provide contact
guidance to axons in vitro, suggesting that axons can sense ECM topography.23 Recently, electron
beam lithography has become widely adopted to engineer a diversity of nanostructured substrates
to conduct in vitro experiments. For example, a controlled nanodisorder surface has been
developed that was proved to be able to modulate the cell adhesion and direct stem cell fate, which
could induce fast osteogenesis from skeletal stem cells.24 As for stiffness cue, for example, tissue
stiffness could substantially change during different stages of the disease. The stiffness of normal
breast tissue is 150 Pa, where the cancerous breast tissue could become 10 times stiffer than normal
tissue.25, 26 The connective tissue of lung is mainly composed of collagens and elastin fibers, where
the elastic moduli are around 1200 MPa and 1 MPa, respectively, during normal condition.27, 28
The expression of collagen and elastin is largely controlled. However, when experiencing
pulmonary fibrosis, the stiffness of the fibrotic lung tissue increases significantly due to the
excessive deposition of collagen, altering the mechanical properties of the ECM, thus changing
the cellular behavior and function.29 Therefore, the ECM has been identified significantly as in
maintaining the steady state of normal tissue while the disruption of homeostasis would potentially
cause the development of disease.30

3

Limitations of current in vitro models for disease therapy and diagnosis
From the perspective of the natural in vivo condition, current in vitro platforms for disease
therapy and diagnosis show significant drawback. The majority of the platforms for cell culture
are established on TCPS, where it is much stiffer (E ~ 3 GPa)31 than the most human tissues in the
actual in vivo condition. Moreover, TCPS is lack of three-dimensional topographical structure as
it is completely flat. Therefore, most of the cells are randomly spread and largely stretched when
cultured on TCPS, which is substantially deviating from their in vivo microenvironment. For
example, a study has shown that substrate stiffness could direct human mesenchymal stem cells
(hMSCs) fate, and the increase of the time that stem cells were cultured on TCPS tended to
modulate hMSCs differentiation to osteoblasts.31 As shown in Figure 1-2 (b), compared to
culturing strictly on soft substrate (So7), increased mechanical dosing on day 10 (DT10/So7)
significantly resulted in hMSCs differentiation towards osteogenesis. When hMSCs were
precultured on TCPS for 1 to 10 days, most hMSCs tended to lose their multipotency and could
only differentiate into osteoblasts.

4

Figure 1-2: hMSCs differentiation directed by pre-culturing them on TCPS for different days. (a)
hMSCs were first cultured on TCPS for 1 day, 5 days and 10 days and then transferred to soft
hydrogel substrate, followed by 7 days of culturing. hMSCs cultured strictly on the soft substrate
from day 0 was used as a control (So7) (b) Immunostaining of PPARγ (green) and OCN (red) of
hMSCs of the aforementioned samples after 7 days culturing on soft hydrogels. (PPARγ is mainly
present in adipose tissue, colon and macrophages, which is often used as adipogenesis marker.
OCN is produced by osteoblasts, which is often used as a biochemical marker for bone formation.)
(c) Staining for ALP (osteogenic markers) of hMSCs of the aforementioned samples before
transferred to soft hydrogels. The scale bars are 20 µm. (Adapted with permission from Ref. [31])
5

The ECM also play a significant role in cell spreading. When cultured on TCPS, cells tend
to increase proliferation and the formation of actin fibers and focal adhesions.32, 33, 34, 35, 36 For
example, one study has shown that increased cell number has been observed due to the promotion
of cell proliferation when cultured on TCPS compared with polyacrylamide (PAAm) hydrogels (~
0.3 to 55 kPa)37 Another study compared the proliferation of cells cultured on TCPS and the
fabricated highly aligned microfibrous tubular scaffold, where the results showed that cell
proliferation was significantly higher on TCPS than the engineered scaffold, which had similar
mechanical properties compared to the native esophagus.38
Therefore, taking the limitations of current in vitro model into consideration, instead of
using flat, rigid TCPS surfaces, novel physiologically relevant platforms that incorporate both
topographical cue and stiffness cue should be established to closely mimic the in vivo conditions.
Biophysical cues modulation of cell phenotype and function
Stiffness cue. A wide range of natural as well as engineered materials with a stiffness
varying from several pascal to hundreds gigapascal that have been applied in different biological
related studies (see Table 1), including hard materials like silicon (Young’s modulus ranging from
50.9 to 180 GPa39), glass (50-90 GPa40), TCPS ( ~ 3 GPa31). However, since the ECM exhibits
various degree of stiffness in the actual in vivo condition, and there are lots of tissues which cover
the range below the magnitude of gigapascal (see Figure 1-1b), engineered soft materials have
been more and more commonly used to conduct in vitro models to mimic the stiffness in different
tissues for disease detection and modeling.
For example, elastic polymer polydimethylsiloxane (PDMS) has been widely adopted as
substrates/ matrices for biological related study, not only because its great biocompatibility, but
6

also for the fact that it is a versatile polymeric material which stiffness could be tuned by varying
the base material and curing agent, as well as the curing time/ temperature. PDMS typically has
an elastic modulus around 1 MPa and holds the great potential of tunable stiffness. One study has
shown the ability to tune the stiffness of PDMS from 800 kPa to 10 MPa by varying the base
material and crosslinker reagent from 1:2 to 1:19 under different curing temperature and time.41 A
much soft stiffness in the lower limit range has been reported that by varying the base material and
crosslinker reagent ratio from 100:1 to 10:1, the PDMS substrates could achieve a range from 0.1
kPa to 2.3 MPa.42 Poly(ethylene glycol) (PEG) based hydrogel is another commonly used soft
material, which has been realized as a suitable, biocompatible soft material that is widely applied
in a diversity of cellular and biomedical related applications, including 3D in vitro model for cell
study,43 cell encapsulation,44 tissue scaffold for regenerative medicine.45 The stiffness of PEG is
highly tunable via the cross-linking polymerization process by varying the ratio between
precursors and cross-linkers. The stiffness of PEG is typically lower than ~1 kPa.46 An elastic
modulus range from 4 kPa to 70 kPa has been reported by using a radical-free, Michael addition
to prepare PEG hydrogel,47, 48 in which range has covered many soft tissues in human body.49 PEGbased hydrogel can also cover a much more rigid elasticity range from 10 kPa to 1 MPa by
changing the cross-linking density and mechanism. Specifically, the protein accumulation effects
by the crosslinking process have been studied and investigated.50 Polyacrylamide (PAAm) gel has
been more and more routinely used as an engineered soft substrate for studying the
mechanosensing in various in vitro models.51 Typically, mostly used PAAm gels are in a very soft
range and the stiffness is ~ 1 kPa but they are also highly tunable by varying the ratio of the two
components for polymerization, acrylamide and bis-acrylamide. A wide range of 1.3-166 kPa has
been reported (Young’s modulus was calculated from shear modulus in the original reference, ν is
7

assumed to be 0.5).52 A wider range has also been reported up to 740 kPa in the upper limit of the
stiffness.42
Table 1-1: Different materials and their stiffness as in Young’s modulus.
Material

Young’s Modulus

Reference

Silicon

50.9-180 GPa

[39]

Glass

50-90 GPa

[40]

TCPS

~ 3 GPa

[31]

0.8-10 MPa

[41]

0.1 kPa – 2.3 MPa

[42]

PDMS

4-70 kPa
PEG

PAAm

[47], [48]

10 kPa – 1 MPa

[50]

1.3-166 kPa

[52]

2 Pa – 55 kPa

[53]

0.5-740 kPa

[42]

The effect of cellular response to different stiffness has been extensively studied. The
variation of stiffness could affect cell adhesion,54 cell spreading area, actin organization and cell
elongation,53, 54, 55, 56 cell migration,54, 55, 56 cell proliferation, growth and apoptosis,57 cellular
contractility,54, 55, 58 and stem cell differentiation.31, 59
Among the studies conducted to investigate the cellular response to substrate stiffness,
fibroblasts have been widely adopted as a cell model, besides, epithelial cells, endothelial cells and
neuron cells were also used. Extensive reports have shown that cell spreading increased with the
increase of substrate stiffness increase, along with a noticeable formation and organization of actin
stress fiber as for fibroblasts.53, 54, 55, 56 For example, one group reported that fibroblasts on soft
substrate (2.68 ± 0.99 kPa) have poor cell adhesion, which results in a poorly spread morphology
8

and has the tendency to aggregate with neighboring cells to form spheroids that are tightly attached
and tissue-like. Moreover, the focal adhesions observed on the soft substrate were short, limited
quantity and dot-like. On the contrary, cells cultured on the stiff substrate (7.69 ± 2.85 kPa) exhibit
similar behavior as that on TCPS surface, with a stronger cell adhesion, elongation, and large cell
spreading area, as well as a great number of large, elongated focal adhesions.54
Cell migration, which is involved in a number of physiological process in vivo, can also be
affected and guided by substrate stiffness in vitro. For example, PAAm hydrogel sheets that
incorporated with different gradient of stiffness have been engineered to test the cell migration of
NIH 3T3 fibroblast cells, with the results showing that preferentially, NIH 3T3 cells tended to
migrate toward the stiff side of the PAAm sheets with a decreased migration speed.55 Another
important aspect is that matrix stiffness can also have an impact on activating the signaling
pathways of cell contractility.58 For example, tumors generally have stiffer elastic moduli than
normal tissues where Rho proteins are found to be overexpressed in stiff tumors.60 Therefore, it
has been found that increased in matrix stiffness resulted in elevated cell contractility because Rho
activity has been identified to be closely associated with generating cell contractility.58, 60, 61
Substrate stiffness also affects cell proliferation, growth and apoptosis. NIH 3T3 cells and
PAAm gels were used in one study to test the cell proliferation affected by different matrix
stiffness, where the cell proliferation showed a 2-fold increase on stiff PAAm gels (0.06% bisacrylamide) compared to that on soft PAAm gels (0.012% bis-acrylamide) after 24 h incubation
and the difference has been increased up to 4-fold after 48 h of incubation.57
Substrate rigidity could also substantially affect stem cell differentiation. For example, one
study investigated the stem cell differentiation directed by matrix stiffness using mesenchymal
9

stem cells (MSCs). Results showed that MSCs on soft substrates (0.1-1 kPa) were largely
differentiated into neurogenic cell types; on intermediate stiff substrates (11 kPa), the
differentiation was directed to myogenic cell types while on the stiffest substrates (34 kPa),
osteogenic differentiation occurred at the most.59 It has been suggested that the direction of MSCs
differentiation tended to develop towards the direction of mimicking the actual in vivo
environment, where these three stiffness represented brain, muscle and bone tissues.62
Given that the mechanical properties of substrates have a wide range of impact on cell
behaviors, substrate stiffness regulation can be well adopted in clinical studies for disease detection
and modeling. One of the applications is the impacts of substrate stiffness on cellular uptake of
nanoparticles for cancer diagnosis and clinical therapy. One systematical study showed that higher
membrane tension that existed in cells on stiffer substrate (3.81 ± 0.12 kPa for intermediate gels
and 5.71 ± 0.51 kPa for stiff gels) caused barrier that prevented the nanoparticles from entering
the cells, whereas cells on soft gels (1.61 ± 0.11 kPa) had lower membrane tension that promoted
the cell uptake of nanoparticles.63 Moreover, this study shed light on the potential application in
cancer cell targeting and detection using nanoparticles to inhibit tumor growth by taking the
advantages of the stiffness different between tumors and normal tissues.63
Nanotopographical cue. Nanotopographical cue has been more and more realized as an
important mechanical property that could modulate cell behaviors for disease detection and
modeling. One of the reasons is that nanoscale topographies existed in numerous human tissues
that are closely related the function of the specific organ (see Figure 1-3). For example, threedimensional hierarchical structures and organizations can be seen in many tissues like bone,
ligaments and tendon, blood vessels.64 Specifically, as shown in Figure 1-3, the bone tissue
contains dense-packed, organized cylindrical structures. Such structures possibly existed because
10

of the supportive and protective function of the bone, which could be able to sustain the possible
external force. Particularly, as previously mentioned, the ECM is composed of a diversity of welldefined, three-dimensional nanostructures such as collagens fibers, elastins, laminins, all of which
have a feature size in the nanometers range, where cells are highly sensitive to.65

Figure 1-3: Nanotopographical features exhibited in various tissues. According to the living
environment and the functions of the tissue, there are four major categories: protective tissues,
mechano-sensitive tissues, electro-active tissues and shear stress-sensitive tissues. (Adapted with
permission from Ref. [64])
Taking the advantage of the rapid evolution of modern nanotechnologies, it is now possible
and convenient to generate the designed nanostructures with various shapes and dimensions. For
11

example, a high resolution with a lateral dimension of 30 nm feature size could be obtained with
two-photon lithography, which could be potentially used in fabricating nanoscale structures with
a large scale like photonic crystals.66 Self-assembly techniques that can fabricate various complex
miro- and nano-sized features, also gain many of the interests in the field of nanofabrication,67
including block copolymer micelle nanolithography (BCMN)68, 69, 70 and colloidal lithography7
were also used to form a large area of nanopatterns at a relatively low cost. Moreover, electron
beam lithography (EBL) and focused ion beam lithography were largely developed to generate
well-defined patterns with a high resolution of ~ 5 nm in recent decades.71, 72 Besides of the high
resolution, EBL technique has other advantages such as fabricating customized patterns,
performing pattern fabrication without a mask and eliminating the diffraction problem. The EBL
fabricated nanotopographies could be further served as the molds to prepare the PDMS replicas.
According to the different shape of the repeating unit of the nanofeature, the designed
nanotopographies that have been used in tissue engineering can be divided into two types, the
isotropic nanotopography (nanopillars, nanopits, nanorod arrays) and the anisotropic
nanotopography (nanogratings, aligned fibers). Besides, there is also nanotopography gradient,
where the isotropic or the anisotropic nanotopography can be presented at a density gradient (see
Figure 1-4).73 Different design, shapes, as well as the variation of dimension of the
nanotopographies, may have different impact on cell behaviors, including cell adhesion, cell
spreading (elongation, alignment), cell migration, and stem cell differentiation.
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Figure 1-4: Classification of nanotopograophies according to the shape, including anisotropic
topography (nanogroove, aligned fibers), isotropic nanotopography (nanopillar, nanopost and
nanopit arrays) and topography gradients. (Adapted with permission from Ref. [73])
Isotropic nanotopographies are uniform, homogeneous repeating units, which provides
discrete contact guidance in every direction. Cell behavior could be altered by isotropic
nanotopographies from numerous aspects including increased74 or reduced cell adhesion,75 limited
cell spreading,76, 77 cell migration78 and directed stem cell differentiation.24, 76 For example, one
group discovered that compared to bare polyethylene glycol (PEG) surfaces, fabricated PEG
nanopillars could enhance the cell adhesion of cultured cardiomyocytes for the reason that those
pillars could not only serve as anchor posts for cell to attach on by extruding filopodia and
13

lamellipodia, but also favor the actin formation.74 The influence of nanotopography on cell
adhesion is highly dependent on the shape of the nanotopography. Another study reported a
reduced adhesion complex formation and a limited cell spreading on highly-ordered nanopit arrays
compared to the planar control.75 It seemed that the nanopit topography could disrupt or inhibit the
adhesion formation. A similar study has been done by fabricating square (sq) and hexagonal (hex)
ordered nanopits that proved to reduce cell spreading and the adhesion formation.77 Cell migration
mostly occurred on anisotropic nanogratings, where there have been limited studies conducted on
isotropic nanotopographies. One study that systematically investigated the mechanical properties
modulated cell migration by combining the substrate stiffness and topographical cues, which
showed that the cell migration was highly dependent on the substrate anisotropy, and the migration
orientation was appeared to be along the spatial direction of pillar arrangement.78 Another
important aspect is the influence on stem cell differentiation. Results suggested that the MSCs
differentiation could be altered by varying the order of isotropic nanotopographies. It was noted
on DSQ50 nanopits, which is a disordered square array with dots displaced randomly by up to 50
nm on both axes from their position in a true square, exhibited bone nodule formation whereas the
highly ordered hexagon and square array decreased the cell adhesion and low amount of
osteoblastic differentiation marker was detected.24
In contrast to the isotropic nanotopographies, anisotropic topographies provide continuous
contact guidance in a single direction, which results in different impact on cell behaviors, including
enhanced cell elongation and alignment,79,

80, 81

increased82 or reduced cell adhesion,81 cell

proliferation,79, 80, 81, 82 directional migration79, 83 and stem cell differentiation.80, 84 For example,
endothelial progenitor cells (EPCs) cultured on nanogratings that featured 1200 nm in width and
600 nm in height showed a highly elongated morphology aligned with the groove direction,
14

reduced cell proliferation and an enhanced directional migration along with an overall high
speed.79 It has also been realized that the influence on cell proliferation may closely related to the
dimension of the nanotopographies. One study showed that compared to flat PDMS, cell
proliferation all showed a reduction on nanogratings with 350 nm, 1 μm and 10 μm in width but it
decreased more significantly as the width getting smaller.80 Other than the lateral dimension of the
nanogratings, height also serves as an important factor in affecting the cell spreading and
proliferation. One study reported that the enhancement or reduction of cell proliferation and cell
spreading followed a height dependent manner. In comparison to control, cell spreading area was
increased on nanogratings with 13 nm in height and decreased on higher islands with 95 nm in
height.85
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Abstract
CTCs shed from primary tumors, transport through the bloodstream to distant sites, and
cause 90% of cancer deaths.1 Although different techniques have been developed to isolate CTCs
for cancer detection, diagnosis and treatment, the heterogeneity of expression of the target antigen
and the significant size variance in CTCs limit clinical applications of antibody- and size-based
isolation techniques. Cell adhesion using nanotopography has been suggested as a promising
approach to isolate CTCs independent of surface marker expression or size of CTCs. However,
the influence of nanotopography configuration (geometry and dimensions) on CTC capture
efficiency has not been investigated. This study examined capture performance of several cancer
cell lines of different types, surface marker expression and metastatic status on nanotopographies
of various geometry and dimensions without antibody conjugation. The cancer cells exhibited
differential capture performance on the nanotopographies with an efficiency up to 52%. Compared
with flat surfaces and isotropic, discrete nanopillars, anisotropic nanogratings favored cancer cell
adhesion, thus improving the capture efficiency. The influence of nanotopography height studied,
on the other hand, was less significant. This study provides useful information to optimize
nanotopography to further improve CTC capture efficiency.
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Introduction
Cancer metastasis, initiated by CTCs migration from primary tumors through the
bloodstream to distant sites of the body, causes 90% of cancer deaths.1 Although the cellular and
molecular characterization of CTCs holds great promise for cancer detection, diagnosis and
treatment, the realization of this potential remains limited by current challenges associated with
CTC isolation techniques.2 The major hurdles in advancing CTC isolation techniques include rarity
and heterogeneity of CTCs. CTCs are extremely rare, as few as one CTC per 109 normal blood
cells in the blood of patients with metastatic cancer.3 CTCs also display heterogeneity in the
expression of target antigens and variation in cell size. Nevertheless, different techniques have
been developed to capture CTCs.
The most widely used CTC capture techniques rely on positive selection based on surface
biomarkers such as epithelial cell adhesion molecule (EpCAM) expression on tumor cells.4 For
instance, CellSearch assay, the most standardized technology, uses ferrofluids loaded with an
EpCAM antibody (anti-EpCAM) to capture CTCs through a magnetic field. The advent of
microfluidic technology advances CTC capture techniques. CTC capture efficiency has been
improved by enhancing CTCs-antibody interactions via optimizing the microchannel dimensions,5
introducing microscale pillars,6 and generating microvortices.7 Although EpCAM is expressed in
the cells of epithelial origin, the EpCAM expression on tumor cells varies with tumor type,8 some
cells even express no EpCAM.9 Additionally, invasive tumor cells tend to lose their epithelial
antigens via the epithelial-to-mesenchymal transition process.10 The antibody-based capture
techniques are thereby limited to the tumor cells expressing the specific antigen.11, 12, 13 Because
of relatively low sensitivity on some tumor cells expressing low or no EpCAM, the CellSearch
assay only achieved a median yield of approximately one CTC per milliliter and typically low
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purity.14,

15

To overcome the limitation of heterogeneous surface marker expression, several

physical properties distinguishing CTCs from most normal blood cells have been utilized to
capture CTCs. The properties include the larger size of most epithelial cells and differences in
density, charge, migratory properties, and some properties of specific cell types (e.g., melanocytic
granules in melanoma cells). 16, 17, 18 For instance, the size-based microsieve and microfiltration
device have been developed to isolate breast, gastric, and colon tumor cells lines including
EpCAM-negative tumor cells.17, 19, 20, 21 However, the fact that CTCs are not always larger than
leukocytes and monocytes have a similar size (15-25 µm) to CTCs22 impedes the clinical
applications of size-based capture techniques.23
Emerging compelling evidence continues to show that substrate nanotopography has a
profound influence on cell adhesion, suggesting cell adhesion as a promising approach to CTCs
capture. Inspired by nanostructured surface (e.g., microvilli, microridges and cilia) of cancer cells24
and enhanced cancer cells-nanotopography interactions,25 silicon nanowires,26, 27 polystyrene (PS)
nanotubes28 and hierarchical nanowire arrays29 have been fabricated and conjugated with antiEpCAM to significantly improve sensitivity and efficiency of CTC capture. Strikingly, by taking
advantage of the differential adhesion preference of cancer cells to nanotopography compared with
normal blood cells, Chen et al. demonstrated high selectivity and high efficiency capture of CTCs
by using nanorough glass surfaces prepared by using reactive ion etching (RIE) regardless of the
surface marker expression or physical size of the CTCs.30 To successfully translate adhesion-based
CTC capture technique using nanotopography to clinical settings, it is highly desirable to
understand how nanotopography configuration parameters such as geometry and dimensions affect
tumor cell adhesion.
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Herein, we investigated capture performance of four human cancer cell lines on
representative nanotopographies. The nanotopographies of various geometry (nanoscale gratings
and pillars) and dimensions (in particular height) were engineered on elastomeric PDMS
substrates. The cancer cell lines were MCF7 (a luminal non-metastatic breast cancer cell line),
MDA-MB-231 (a basal aggressive metastatic breast cancer cell line), A549 (an adenocarcinomic
basal epithelial cell line), and HeLa (a cervical cancer cell line). Thereby, we were able to examine
the influence of geometry and dimensions of nanotopography on cell adhesion and capture
performance of the cancer cells of different cell types, surface marker expression (EpCAM positive
MCF7 and A549 cells vs EpCAM negative MDA-MB-231 and HeLa cells), and metastatic status
(non-metastatic MCF7 vs metastatic MDA-MB-231). This study helped our understanding of
nanotopography enhanced CTC capture.
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Materials and Methods
Cell culture
All cancer cell lines were purchased from American Type Culture Collection (ATCC;
Manassas, VA). MCF7 were cultured in Eagle's Minimum Essential Medium (EMEM; ATCC)
supplemented with 10% (v/v) fetal bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA),
1% (v/v) penicillin/streptomycin (Life Technologies, Carlsbad, CA) and 0.01 mg/ml human
recombinant insulin (Sigma-Aldrich, St Louis, MO). MDA-MB-231 were cultured in Minimum
Essential Media (MEM; Thermo Fisher Scientific) supplemented with 10% (v/v) FBS, 1% (v/v)
L-glutamine (Life Technologies) and 1% (v/v) penicillin/streptomycin. HeLa and A549 cells were
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma-Aldrich) supplemented with
10% (v/v) FBS, 1% (v/v) L-glutamine 1% (v/v) penicillin/streptomycin. The cultures were
maintained at 37˚C in a humidified atmosphere containing 5% CO2. The culture media was
replaced every 3 days.
Preparation of nanotopographies
Nanotopography was generated by using EBL and replicated into PDMS substrate as
previously described.31,
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Briefly, the nanopattern was designed and written onto a

poly(methylmethacrylate) (PMMA) thin film on a silicon substrate by using EBL and then etched
in the silicon substrate by applying RIE process. The generated nanotopography was cast with a
mixture of PDMS resin and curing agent (Sylgard 184 silicone elastomer kit; Corning, Corning,
NY) at a 10:1.05 w/w ratio, followed by curing at 70 C for 4 h. The PDMS nanotopography was
expanded to a large area by applying a stitch technique.33 The stitched mold was then imprinted
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into PS substrates to make a PS master mold, from which working PDMS nanotopographies were
produced.
The working PDMS nanotopographies were punched to discs fitting in the wells of a 48well plate. The discs were oxygen plasma treated at 300 mT, 50 W for 30 s in a PX-250 Plasma
Asher (Nordson MARCH, Concord, CA) to render a hydrophilic surface. The PDMS
nanotopographies and flat surfaces as control were sterilized in 70% ethanol followed by UV
exposure, each for 30 min, and then incubated with 5 µg/cm2 collagen I (Corning) for 1 h prior to
cell seeding.
Cancer cell capture
The cancer cells were first labeled with either CellTracker Green or CellTracker Red (Life
Technologies) according to the manufacturer’s instruction. Briefly, the cells were incubated in 5
mM CellTracker in DMEM solution (serum free) at 37˚C for 30 min. The cells were then
trypsinized using 0.25% trypsin-EDTA (Sigma-Aldrich) after phosphate buffer saline (PBS;
Sigma-Aldrich) rinse, resuspended in 1 mL fresh media, and diluted to the desired seeding density
of 500 cells/well. The cell suspension was added onto the PDMS discs in 48-well plates and
incubated for a predefined capture time (1 h, 2 h or 4 h).
To achieve accurate cell counting, the whole PDMS surface with the cells was first scanned
by using a Nikon Swept Field microscope with a 10x objective (Nikon, Melville, NY) at the
predefined time point. Multiple images from the scanned field of 1 cm x 1.03 cm rectangle were
stitched to a single image using Nikon NIS-Element software, covering the whole well of 48-well
plates. Subsequently, the culture media was carefully aspirated and the sample was gently rinsed
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with PBS to remove any non-adhered cells. The PDMS disc with captured cells was scanned again
to count the captured cells by repeating the aforementioned scanning process.
ImageJ (http://imagej.nih.gov/ij/) was used to quantify the numbers of seeded cells and
captured cells using the “analyze particle” function. The cells were highlighted by adjusting the
threshold and the image was converted to a binary image prior to analyzing the particles.
Cell area measurement
MCF7 cells were pre-labeled with CellTracker Red and seeded at a density of 1000
cells/cm2 on the PDMS substrates including nanotopographies and flat surfaces. After 4 h
cultivation, the cells were fixed using 4% paraformaldehyde (PFA; Electron Microscopy Sciences,
Hatfield, PA) in PBS for 30 min, and mounted on a coverglass using ProLong Gold Antifade
Reagent with 4,6-diamidino-2-phenylindole (DAPI; Life Technologies) overnight at room
temperature. At least 50 cells were imaged using a Nikon Swept Field microscope with 40x oil
objective. Cell area was quantified using ImageJ software. Firstly, the cells were highlighted by
adjusting the threshold and the image was converted to a binary image. After the scale has been
properly calibrated, the areas of the cells were measured using ROI (Region of Interest)
manager.
SEM observations
The substrates with cells grown were rinsed with PBS and fixed in a mixture of 4% PFA
and 2% glutaraldehyde (Thermo Fisher Scientific) in PBS at ambient for 4 h. The samples were
then rinsed with deionized (DI) water and progressively dehydrated using a Baltec CO2 critical
point dryer (Bal-Tec, Los Angeles, CA). The substrates with(out) cells grown were sputter-coated
with a gold layer of ~10 nm thick by using a Denton Vacuum Desk V sputter unit (Denton Vacuum,
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LLC, Moorestown, NJ, USA), and imaged in a field emission SEM (JEOL JSM-7600F, Peabody,
MA).
Statistical analysis
Capture efficiency and cell areas were expressed as mean ± standard error of mean (S.E.M).
The differences between groups were analyzed by one-way ANOVA using student T-test for
multiple comparisons at a confidence interval level of 95%.
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Results and Discussion
Design of nanotopographies
Recent studies indicated that nanotopography modulated cell phenotype and function were
dictated by the geometry (e.g., gratings, pillars and wells), dimensions and arrangement of
nanofeatures, which is cell type-specific.34, 35, 36, 37, 38, 39 Our studies also demonstrated that cell
adhesion, nuclear volume and cell function such as proliferation, transfection and ECM protein
production of human lung fibroblasts could be modulated by the geometry (nanoscale anisotropic
gratings and pillars) and dimensions, in particular the height of nanotopography.31 In light of our
previous results, we chose representative nanogratings (NGs) and nanopillars (NPs) of various
heights in this study (see Figure 2-1). The nanotopographies had the same feature size (500 nm in
line width of NGs and diameter of NPs), similar spacing (500 and 450 nm for the edge-to-edge
spacing of NGs and NPs, respectively) and two heights (150 and 560 nm). Additionally, equally
spaced nanogratings of 1000 nm in line width were fabricated, which had 15% and 56% surface
area increase for 150 and 560 nm heights, respectively. For the convenience of discussion, the
nanotopography was labeled by using a combination of feature size, edge-to-edge spacing and
height. For example, 500-0.9-150 referred to the nanogratings of 500 nm in diameter, 0.9 times
edge-to-edge distance (450 nm) in spacing and 150 nm in height. The lateral dimensions of
nanotopographies were defined by EBL and confirmed by using SEM, and the height was
controlled by RIE processing time and measure by using atomic force microscope (AFM).31 Such
design of nanotopographies allowed systematic investigation of capture performance of different
cancer cells on nanotopography of various configuration parameters (geometry and height).
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Figure 2-1: SEM micrographs of the PDMS nanotopographies and the flat substrate. The scale
bars are 1 μm.
MCF7 cell capture on nanotopographies
We first examined the capture efficiency of MCF7 cells on the nanotopographies as a
function of incubation time. Capture efficiency was defined as the ratio of the number of cells
adhered to the substrate surface to the number of cells initially seeded. To avoid possible errors in
initial cell counting from the cell suspension preparation step, the seeded cells were precisely
counted by scanning the whole PDMS surface after the predefined time, but before rinsing off the
non-adherent cells. Because early cell-nanotopography interactions were critical to
mechanosensing40 and the reported CTC capture experiment was usually performed within 4 h,26,
30, 41

the incubation time was determined at 1, 2 and 4 h. At all the time points, it was observed that

some cells were captured on the PDMS substrates including the nanotopographies and the flat
surfaces, as exemplified in Figure 2-2A. The measurement showed that on the same PDMS
substrate, the capture efficiency increased as a function of the incubation time (see Figure 2-2B).
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The capture efficiency on the flat surfaces and the nanopillars slightly increased over time. For
instance, the efficiency on the flat surfaces increased from 3.1 ± 1.5% at 1 h to 4.3 ± 2.0% and
10.4 ± 2.3% at 2 and 4 h, respectively. By contrast, the nanogratings displayed a remarkable
enhancement on MCF7 capture, and the efficiency reached up to 41.0 ± 5.0% on 500-1-150 at 4
h. For the same nanotopography geometry, the decrease in height did not result in significantly
different capture efficiency on the nanopillars (except the capture at 2 h), yet improved MCF7
capture on the nanogratings, 20.7 ± 1.3% on 500-1-560 vs 29.1 ± 0.3% on 500-1-150 at 2 h, and
27.9 ± 3.9% on 500-1-560 vs 41.0 ± 5.0% on 500-1-150 at 4 h. The results suggested that while
the nanotopographies could improve CTC capture, the nanogratings were more effective on MCF7
capture than the nanopillars, and increase in the height of nanogratings undermined MCF7 cell
capture.
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Figure 2-2: MCF7 cell capture on the nanotopographies. (A) Fluorescent images of MCF7
captured on nanogratings 500-1-150. Top row: Field scan images of MCF7 cells captured at 1, 2
40

and 4 h of incubation time. The scale bars are 2 mm. Bottom row: enlarged view of boxed area in
the top row. The arrows point to the captured cells in red. The scale bars are 250 μm. (B) Capture
efficiency of MCF7 on the nanotopographies as a function of time. *: Significant different (p <
0.05) from the flat controls and #: significant difference (p < 0.05) between two groups.
Intuitively, enhanced cell adhesion was associated with a larger cell area. We thus
measured the cell spreading area and examined its correlation with capture efficiency on the
nanotopographies. As shown in Figure 2-3A, MCF7 cells displayed approximately round
morphology on the flat surfaces and the nanopillars but a mixture of round and partially elongated
morphology on the nanogratings (SEM images in Figure 2-4). Cell area measurement summarized
in Figure 2-3B revealed that MCF7 cells on the nanogratings exhibited average areas (418.8 ± 21.5
μm2 on 500-1-150, and 443.8 ± 22.0 μm2 on 500-1-560) similar to the flat controls (410.84 ±
13.96 μm2), but significantly larger than those on the nanopillars (107.77 ± 5.13 μm2 on 500-1.9150, and 155.63 ± 10.62 μm2 on 500-1.9-560) (p < 0.001). It was also noted that cell areas on the
deeper nanotopographies were larger than their shallow counterparts. The observation that the
nanogratings induced a larger cell area than the nanopillars was consistent with the MCF7 capture
results, indicating increased cell spreading area facilitated the cell capture. However, the increase
in height of the nanotopographies from 150 to 560 nm, accompanied with an increased substrate
surface area, resulted in an enlarged the cell area, contradictory to the influence of height on MCF7
capture efficiency. To further understand nanotopography modulated cell adhesion, we examined
cell-nanotopography interactions by conducting SEM observations. As shown in Figure 2-4,
MCF7 cells were well spread on the flat surfaces. However, the cells displayed a round and
compact morphology on the nanopillars. The cells on the nanogratings, on the other hand, spread
along the nanograting direction. Moreover, the protrusion of lamellipodia and filopodia on the
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nanotopographies was not obviously affected by the height difference. It was speculated that
although the increase in the height enlarged the area of adherent cells, the adhesion of non-invasive
MCF7 on the deeper nanotopography might be weakened, leading to decreased capture efficiency.
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Figure 2-3: (A) Fluorescent images of captured MCF7 cells on the nanotopographies and flat
surfaces. The cell was labeled with CellTracker (red) and the nucleus was stained with DAPI
(blue). The scale bars are 10 μm. (B) Cell area measurement of captured MCF7 cells on the
nanotopographies and flat surfaces. *: Significant different (p < 0.05) from the flat controls and #:
significant difference (p < 0.05) between two groups.

Figure 2-4: SEM micrographs of MCF7 cells adhered to the nanotopographies and flat surface.
Insets provide an enlarged view of cell-substrate interactions from the boxed area. The scale bars
are 10 μm.
It has been suggested that isotropic nanopillars tend to decrease the surface wettability, and
consequently reduce protein adsorption, leading to an unfavorable cell adhesion.42, 43 That provides
a possible explanation for differential influence of nanogratings versus nanopillars on MCF7 cell
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capture. Our previous study suggests that the anisotropic nanogratings provide continuous contact
guidance for the formation and growth of focal adhesions, thus promoting cell adhesion. The
highly ordered, discrete nanopillars, on the contrary, tend to disrupt the development of focal
adhesions, accompanied with reduced cell spreading area. Evidently, anisotropic nanogratings are
favorable for cell adhesion, leading to increased capture efficiency.
Cell type specific capture on nanotopographies
We further explored nanotopography enhanced CTC capture by extending to more cancer
cells of different cell types, surface marker expression and metastatic status. Given the increased
MCF7 capture efficiency with incubation time and commonly used capture duration, we assessed
CTC capture performance only at 4 h and summarized it in Figure 2-5.
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Figure 2-5: Capture efficiency of MCF7, A549, MDA-MB-231 and HeLa cells after 4 h of
incubation on the nanotopographies and flat surfaces. *: Significant different (p < 0.05) from the
flat controls and #: significant difference (p < 0.05) between two groups.
A549 lung cancer cells were EpCAM positive similar to MCF7 cells, but demonstrated
different capture efficiency from MCF7 cells in response to the alteration in geometry and height
of the nanotopographies. Deeper nanotopography achieved significantly higher capture efficiency
than its shallow counterpart, i.e., 51.7 ± 4.9% on 500-1-560 vs 38.2 ± 3.3% on 500-1-150 (p <
0.0371), and 47.5 ± 2.2% on 500-0.9-560 vs 29.7 ± 4.0% on 500-0.9-150 (p < 0.0141). By
comparison, MCF7 cells reached the highest efficiency on the shallow nanogratings 500-1-150.
The nanogratings also increased the capture efficiency compared with the nanopillars of the same
height, but not statistically significant. The observations indicated that A549 cells were sensitive
to the height yet not to the geometry of nanotopography. SEM observations showed that A549
cells on all nanotopographies spread more than the flat controls (see Figure 2-6A). Although the
cells distributed randomly on the nanopillars and stretched along nanogratings, the
nanotopography geometry did not have evident influence on cell area.
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Figure 2-6: SEM micrographs of (A) A549 and (B) HeLa cells on the nanotopographies and flat
surfaces. The scale bars are 10 μm.
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Compared to non-metastatic MCF7 cells, the aggressive metastatic MDA-MB-231 breast
cancer cells exhibited similar yet different capture performance on the nanotopographies. MDAMB-231 cells captured on the nanogratings reached relatively higher efficiency, indicating that the
nanogratings could more effectively enhance the cell adhesion than the nanopillars. However, the
influence of nanotopography height on the cell capture was not significant. It was speculated that
MDA-MB-231 cells, different from the epithelial-like MCF7 cells, were mesenchymal-like cells
and invasive, and thus could readily reach the bottom of the nanotopography. In this regard, the
difference in cell-nanotopography adhesion caused by the height change imposed insignificant
influence on the cell capture.
EpCAM negative HeLa cells displayed similarity and difference in the capture
performance on the nanotopographies in comparison with MCF7 and A549 cells. The nanogratings
favored HeLa cell capture compared with the nanopillars of the same height, which was similar to
MCF7 cells but different from A549 cells. Deeper nanotopographies, on the other hand, improved
the capture efficiency, which was similar to A549 cells but different from MCF7 cells. Compared
with A549 cells, HeLa cells were more sensitive to geometry but less sensitive to the height, which
was supported by the SEM observations (see Figure 2-6B).
Despite the differential capture efficiency that these cancer cells demonstrated on the
nanotopographies, general trends were observed regarding the influence of nanotopography on
CTC capture. The nanogratings usually favored cancer cell adhesion. For example, the capture
efficiency on the nanogratings was significantly higher than that on the nanopillars of the same
height for MCF7, MDA-MB-231 and HeLa cells. The capture efficiency of A549 cells on the
nanogratings was also slightly higher than that on the nanopillars. In current study, increase in
height can help capture of these cancer cells, in particular A549 cells.
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Compared to high capture efficiency using anti-EpCAM modified nanotopographies, the
capture efficiency demonstrated in this study was relatively low (up to 52%). In this study, the
height of the nanotopographies was up to 560 nm, far shorter than 2.6 m, the reported
characteristic length of long brushes of cancer cells.24 In addition to the antibody enhancement,
the previous studies used nanopillars of a height up to 12-15 m26, which significantly improve
cell-nanotopography interactions. The RIE generated glass surfaces, which had a roughness of 150
nm but no anti-EpCAM conjugation, could achieve an efficiency of up to 80%.30 The improved
CTC capture could be attributed to the higher surface free energy of RIE-etched glass surface
compared to RIE-treated PDMS substrates. In light of the current study, the CTC capture
efficiency is expected to be improved by optimizing the configuration of nanotopography and
surface modification.
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Conclusion
While more and more studies have been done to realize the significant role that
nanotopography played in regulating cell behavior, there have been increased applications in the
clinical settings as well. This study fabricated two types of nanotopographies: anisotropic
nanogratings and isotropic nanopillars by using EBL and incorporated nanotopographical cue into
disease detection for CTCs capture, which systematically evaluated the influence of
nanotopography configuration, i.e., geometry and dimension on capture performance of human
cancer cell lines of different cell types, surface marker expression and metastatic status. The results
showed that compared to flat substrates, nanotopography could enhance cell adhesion and thus
improved capture efficiency. Generally speaking, the nanogratings improved cell adhesion and
facilitated cancer cell capture although the capture efficiency was also cell type specific. The
cancer cells were less sensitive to the height range studied.
For MCF7 cells, the capture efficiency could reach up to 41% on 500-1×-150 nm
nanogratings after 4 hours of incubation, suggesting that although nanotopography could enhance
cell adhesion, nanogratings were more favorable for cell capture compared to nanopillars. The cell
spreading area measurement revealed that cells on nanogratings exhibited significantly larger area
than that on nanopillars. SEM observations also showed enhanced cell-substrate interactions on
nanogratings for all four types of cancer cell lines compared to nanopillars and flat surfaces.
The significance of this study is to systematically investigate the effects of shapes and
dimensions of nanotopographies on tumor cell capturing. The novelty of our study is to identify
the enhanced cell adhesion by nanogratings and apply the nanotopography into adhesion-based
CTCs capture while most studies have been focusing on fabricating nanopillar arrays to perform
49

CTCs capture by enhanced cell-substrate interaction. Our study shows that the nanogratings can
provide continuous contact guidance for focal adhesion formation while discrete nanopillars
disrupt the growth of focal adhesions. Meanwhile, the research focus on nanogratings affected cell
behavior mostly landed on cell alignment, while we explored the enhanced cell adhesion that
caused by the continuous contact guidance provided by nanogratings, which was also a novelty
for this study. By optimizing the nanotopography configuration and performing appropriate
surface modification for different types of cancer cell lines, the CTCs capture efficiency was
expected to be improved. This study is expected to shed light on optimization of nanotopography
to improve adhesion-based CTC capture technique for disease detection.
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Chapter 3: Incorporating Substrate Stiffness for
Disease Modeling – In Vitro Model of Cell Sensing
Nanomaterials

Abstract
As the rapid development of modern nanotechnology, engineered nanomaterials have been
used in a wide range of fields because of their unique properties, including physics, chemistry,
biochemistry, biomedical engineering, and so many other disciplines. In the same time, an arising
issue has been more and more realized by the researchers that nanomaterials toxicity may cause
potential risk to the human body.
This study focused on understanding the effects of substrate stiffness on fibrogenic
responses of human lung fibroblasts to multi-wall carbon nanotubes (MWCNTs). In most living
tissue, cells resident in a complex microenvironment where these cells interact with the ECM and
the neighboring cells. The interactions between cells and ECM could regulate the cell behavior.
Similar to in vivo, in vitro models have been reported that cells have the ability to sense the stiffness
of synthetic substrate and, the variation of substrate stiffness could affect cell phenotype and
function. Most existing in vitro models focused on conducting the experiment using the rigid TCPS
surfaces, which were much stiffer than the actual in vivo cell microenvironment. Thus, the behavior
and nanomaterial responsiveness of cells could be largely changed due to the deviation of substrate
stiffness when cultured on TCPS. Therefore, it is of the critical need to create physiologically
relevant tissue models to mimic the in vivo environment by introducing stiffness cue.
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This study used the synthesized polyacrylamide (PAAm) hydrogel to represent the normal
and fibrotic conditions of lung tissues to conduct in vitro models. The fibrogenic responses and
mechanosensing of fibroblasts to MWCNTs at different stiffness conditions have been explored.
This study provides an understanding of the regulatory pathways and mediators of fibrogenic
activities, which will potentially help identify therapeutic targets against fibrosis.
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Introduction
Cells live in a dynamic microenvironment that is regulated by the ECM. ECM is a network
composed of a wide variety of macromolecules secreted by cells, including the fibers such as
collagen, which is the most abundant protein in ECM, even in human body.1, 2 A majority of the
composition of ECM have been known to have a nanoscaled structure, like the collagen I fibrils,
which are 300 nm-long, staggered large-diameter banded fibrils typically found in lung, bone and
skin tissue.3 The intrinsic diverse composition of ECM contributes to the fact that it could serve
many functions, including supporting and interacting with the surrounding cells,4 providing
various growth factors, exchanging signals with cells to control the local environment.5 Depending
on ECM composition and interstitial fluid, the ECM exhibits various degree of stiffness, ranging
from <1 kPa to >1 GPa for human tissues.6, 7 A growing body of evidence has shown that the
mechanical cues of ECM critically influence numerous developmental, physiological and
pathological processes in vivo,8, 9 and have a profound influence on cell phenotype and function in
vitro.10
Inspired by the composition of ECM and cell microenvironment, a number of researches
have been conducted to study the influence of surface topography and substrate stiffness on cell
behavior. It has been found that cell could be highly sensitive when responding to a synthetic
surface with different topographical cues as well as stiffness cues. This study focused on how
substrate stiffness regulated cell phenotype and function. Figure 3-1 shows a schematic illustration
of changes in cell behavior when changing the matrix stiffness from soft to stiff.11, 12
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Figure 3-1: Cell behaviors regulated by the variation of matrix mechanics. This schematic
illustration shows several behavioral changes (cell growth, proliferation, apoptosis, cell migration,
cell adhesion, cell spreading and fibrogenesis response) when changing the matrix stiffness from
soft to stiff. (Adapted with permission from Ref. [11])
Generally speaking, cells on soft substrate tends to be rounded and less adhesive and
proliferative while on the contrary, cells on the stiff substrate are more proliferative and fibrogenic.
Focal adhesions (FAs), as the first and essential step of cell responding to the substrate, have been
seen on the stiff matrix and the cells have a spread phenotype. The dynamic changes of focal
adhesion induced by substrate stiffness could largely have an impact on cell phenotype and
eventually cell function. The signally pathway of cell sensing substrate stiffness as well as surface
topography are shown in Figure 3-2.13
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Figure 3-2: Cell contractility, motility and spreading influenced by the mechanical properties of
the substrate. (Adapted with permission from Ref. [13]) (A) Influence of substrate stiffness and
topography on cell contractility as described by physical and biochemical signally pathways.14 (B)
Cell motility speed and traction force change with the increase of gel stiffness. Cells tend to have
higher motility speed with less tension on soft substrate,15 which results in migration from soft
towards stiff on a gradient gel.16 (C) Nonlinear response obtained from a thermodynamic model
of cell spreading area versus collagen density and gel elasticity.17
In our study, we conducted an in vitro tissue model based on using the stiffness cue to
regulate cell phenotype and function through cell-substrate interaction to examine the cellular
response to MWCNTs.
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While the quick development of synthesizing advanced nanomaterials, the toxicity of the
nanomaterials to human body has more and more been realized by the researchers. For example,
CNTs, a novel material that has been used in a variety of biomedical applications as intracellular
transporters due to their intrinsic ability to cross cell membranes.18 Like many other synthetic
nanomaterials, CNTs have been rapidly developed for the past decade, which brought an
increasing concern of its toxicity to the human body. CNTs could cause potential damage to human
lung tissue by inhalation and enter into the respiratory tract.19 CNTs interacts with lung fibroblasts
could cause damage to the tissue and has been reported to be responsible for lung fibrosis.20 Other
injuries to the lung could occur like inflammation and tissue damage. The invasion of CNTs to
fibroblasts could result in many biological changes including cell proliferation, differentiation and
collagen production.19 The activation and proliferation fibroblast could cause the disturbances of
collagen production, which leads to fibrosis.21 The increase of collagen production could be a sign
of lung fibrosis.22
Thus, it is of great significance to evaluate the potential toxic effects of CNTs. Both in
vivo23, 24, 25 and in vitro26, 27, 28 studies have been conducted to assess their toxicity and influence
on causing cellular dysfunction. To evaluate the toxicity of nanomaterials, animal studies are
necessary but expensive, time-consuming and facility limited; while the most important limitation
of current in vitro models using flat, stiff plastic surfaces under static conditions is that they do not
recapitulate characteristics of the ECM with which cells interact in vivo and thus cell behaviors on
such surfaces significantly deviate from their in vivo counterparts.10 Cell could sense the
environment and respond to the physical signals that pass through the substrate. Therefore, cell
could behave completely different when culturing on stiff substrate compared to the actual in vivo
situation. Therefore, it is of great significance to develop in vitro biomimetic models which can
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provide reliable, rapid and inexpensive methods for toxicity testing and risk assessment of
nanomaterials. By taking the stiffness cues into consideration to evaluate the cell sensing
nanomaterials, we could physiologically mimic the cell microenvironment, thus providing more
convincing results.
A number of researches have been done using fibroblasts as a cell model to study the cell
response to substrate elasticity from a variety of perspective.29, 30, 31, 32 Figure 3-3 here shows the
effect of substrate stiffness on stress fibers of fibroblast. Stress fibers are more prominent in cells
that are grown on rigid than on soft substrates.33
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Figure 3-3: Effect of substrate stiffness on cell elongation and polarization. Human foreskin
fibroblasts (HFFs) were fixed with 3% PFA in PBS containing 0.25% Triton X-100 6 h after cell
seeding and immunofluorescent stained with TRITC–phalloidin. The images show HFFs
spreading on glass coated with fibronectin or engineered substrates PDMS (a) or PAAm (b) with
various stiffness. The scale bar is 40 µm. (Reproduced with permission from Ref. [34])
So far, few reports have been shown to integrate the stiffness cue into the toxicity study for
cellular response to CNTs. In this study, our hypothesis is that substrate stiffness can regulate
fibroblast sensing CNTs through cell-substrate interaction. Therefore, the objective of this project
is to develop an in vitro cell-based model integrated with stiffness cues of physiological relevance
to assess the toxicity of nanomaterials. In this view, we systematically investigated the stiffness
effects on the fibrogenic response of normal human lung fibroblasts (NHLFs) to MWCNTs.
Toxicity study
Currently, both in vivo and in vitro have been established for toxicity study. Animal models
have been used to test the toxicity effect by injecting the CNTs to animals.35 Pulmonary
inflammation and fibrotic reactions have been widely observed during the in vivo study.23, 24, 25, 36,
37

Though in vivo study could provide a reliable result, it has the intrinsic limitation of complex

process, expensive and humanity. In vitro study, however, is more controllable and easy.
Traditionally, in vitro studies for toxicity are mostly based on rigid TCPS plate. Few reports have
emerged of toxicity study of fibroblasts on substrate tunable stiffness. In fact, the elastic moduli
of TCPS are much more rigid than lung tissue,38 leading to an unavoidable drawback of the most
in vitro study – it cannot physiologically mimic the in vivo microenvironment, as cell phenotypes
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and function could be largely regulated by its environment.12 Thus, it is critical to develop a
physiologically relevant in vitro model for toxicity study.
Cellular responses to substrate stiffness cue
Cells live in a complex microenvironment, which is composed of the ECM and the
neighboring cells. ECM is secreted by cells and, conversely, giving support to the surrounding
cells.4 The elasticity of ECM from different tissue can vary from soft to stiff, based on the function
of the different organ. The stiffness of ECM has recently been shown to have a great impact on
cell phenotype and regulating cell functions, including cell contraction13, cell proliferation39 and
cell migration40. Therefore, by engineering a substrate with tunable stiffness, we could try to mimic
the in vivo tissue softness instead of using the TCPS rigid culture plate doing in vitro study.
Besides, cellular responses to different substrate stiffness could also be studied, which could guide
us to develop a biomimetic cell culture platform to closely mimic the in vivo microenvironment.
Furthermore, by optimizing the substrate, we can systematically assess the toxicity testing in a
more reliable way.
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Materials and Methods
Preparation of PAAm hydrogel substrate
The protocol of synthesizing PAAm hydrogel has been widely reported.41, 42, 43, 44 We chose
two different stiffness: 3 kPa and 100 kPa to represent the range from soft to stiff. Different from
conventional stiff TCPS (reported Young’s modulus 3.6 GPa45), 3 kPa could physiologically
mimic the stiffness of lung tissue as reported normal lung tissue has Young’s modulus varying
from 1-5 kPa.38, 46 However, studies have shown that fibrotic lung tissue is much stiffer, where the
stiffness could range from 20-100 kPa.38, 47 The process of preparing PAAm gel for cell study
based on the “sandwich-gel” approach is shown in Figure 3-4.44 Briefly, there are 5 major steps:
1) Activate the surface of coverglass. This process is critical because it will allow PAAm
gel to adhere to the glass surface. Failing of the activation process will result in gel
peeling from the coverglass.
Firstly, 25 mm coverslips were cleaned by immersing in 70% ethanol and sonicating
for approximately 1-2 min. The coverslips were air dried or dried by Kimwipes. After
the coverglass was completely cleaned and dried, they were placed in glass dishes
which are 10 mm in diameter (approximate 6-8 coverslips per dish for 25 mm
coverslips) and then immersed with 0.1 M NaOH. Carefully do not let coverslips
overlap each other, placing them as far from each other as possible and then incubate
for

3

min.

While

waiting

for

the

incubation

of

NaOH,

0.5%

(3-

aminopropyl)trimethoxysilane (3-APTMS) were prepared (approximate 25 mL for one
dish) in the chemical hood by diluting 97% stock solution in DI water. After 3 min
incubation was completed, NaOH was recycled to the same bottle.
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Secondly, working inside the chemical hood, all coverslips were then immersed with
prepared 0.5% 3-APTMS, and then incubated for 30 min. While waiting for the
incubation of 3-APTMS, 0.5% glutaraldehyde (approximate 25 mL for one dish) were
prepared in the chemical hood by diluting 50% stock solution in DI water. (Note: 0.5%
glutaraldehyde must be freshly prepared) After 30 min incubation of 3-APTMS, the
chemical was disposed into its own waste container. The coverslips were rinsed with
DI water in the same dish three times on rocker (little less or equal to the maximum
speed), for 10 min each wash.
Finally, after three times wash was completed, all coverslips were immersed in
prepared 0.5% glutaraldehyde solution and incubated for another 30 min. After 30 min,
glutaraldehyde was disposed into its own waste container. Rinse the coverslips again
three times as described previously. After three times wash was completed, the
coverslips were dried completely using Kimwipe. The coverslips activation was
completed and it could be good for several weeks in a dry area.
2) PAAm gel polymerization. There are four components involved in the polymerization
process: acrylamide, N,N′-Methylenebis(acrylamide), Ammonium persulfate (APS)
and N,N,N′,N′-Tetramethylethylenediamine (TEMED).
Firstly, prepare every component for gel polymerization: 40% acrylamide (A)
stocking solution, 2% bis-acrylamide (B) stocking solution, 50 mM 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, 10% APS and
TEMED. 40% acrylamide stocking solution was prepared by dissolving acrylamide
powder into DI water by wt% to achieve the desired concentration. The preparation of
2% bis-acrylamide stocking solution was similar as described above. 50 mM HEPES
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buffer was first prepared by first dissolving HEPES powder in DI water to achieve a
concentration of 1M. Dilute 1 M HEPES solution with DI water to achieve the final
concentration of 50 mM. Using NaOH or HCl and a pH meter to adjust the pH to 8.2.
The 50 mM HEPES solution was autoclaved prior to use. 10% APS was prepared by
dissolving ammonium persulfate powder into DI water by wt% to achieve the desired
concentration. Then the stocking solution was aliquoted into small tubes with 100 µL
per tube and stored in -20℃ freezer.
Secondly, PAAm gel was prepared by mixing A stocking solution, B stocking
solution first, then HEPES buffer was added to reach the desired acrylamide
percentage. To be able to tune the stiffness, the concentration of A and B was varied
during the mixing process according to Table 1. Then working in the chemical hood,
for 500 µL polyacrylamide solution, 1.5 µL TEMED were added to the solution, after
mixing a little bit by vortex, 5 µL 10% APS was added to the mixture. The mixture was
then vortexed again.
Finally, 115-120 µL (for each 25 mm coverslip) drop of the solution was pipetted on
a big square glass plate (glass plate were pre-treated both sides with rain-x solution to
make both surfaces hydrophobic). The activated coverslips were quickly placed on top
of each drop before it began to polymerize. The "sandwich" gels were incubated at
room temperature for approximately 20 min or until the gels are fully polymerized.
After polymerization, the coverslips were carefully peeled off from the glass plate,
PAAm gels stayed on coverslips. Immerse PAAm gels in 50 mM HEPES buffer
overnight to achieve equilibrium.
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Table 3-1: Polyacrylamide Young’s modulus table. The formula shows the amount needed for
acrylamide (A), bis-acrylamide (B), HEPES, TEMED and 10% APS to make a 500 µL mixture
for the desired Young’s modulus.
PAAm
Final
40%
2% Bis50 mM TEMED 10% Young’s
stiffness concentration Acrylamide acrylamide HEPES
(µL)
APS modulus
A+B
(µL)
(µL)
(µL)
(µL)
(kPa)
Soft

5% + 0.1%

62.5

25

412.5

1.5

5

3

Rigid

12% +0.5%

150

125

225

1.5

5

100

3) Activate PAAm gel surface. This process is critical for cell study because it will allow
ECM conjugation on the PAAm surface. Failing of activation PAAm gel will result in
cell detaching from the gel surface.
Firstly, a sheet of parafilm was placed on the bottom of a big petri dish. A vial of 24
µL aliquoted sulfosuccinimidyl 6-(4′-azido-2′-nitrophenylamino)hexanoate (sulfoSANPAH) was thawed at room temperature, then 600 µL 50 mM HEPEs buffer was
added to the vial to make a 1 mg/mL work solution (sulfo-SANPAH was 25 mg/mL in
DMSO).
Secondly, the gels were taken out of the HEPES buffer and the excess buffer was
wicked off with a Kimwipe. The coverslips were placed on the parafilm sheet supported
by a 150-mm petri dish with gel side up. 200 µL working solution was added to each
gel (for a 25 mm coverslip). The petri dish was placed under UV lamp and the distance
between the top of the gel and the UV lamp was 5 cm. The gels were under long wave
exposure for 6 min and then the chemical was carefully sucked out using Kimwipe.
The PAAm gels were placed back into UV chamber in the same position and were
under UV exposure for another 6 min.
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Finally, the PAAm gels were taken out of the UV chamber and immersed into
HEPES buffer solution. The gels were washed with HEPES buffer three times for 10
min each, until the red color fade away.
4) Coat PAAm gel with ECM protein. Fibronectin coating on the activated PAAm gel
surface to allow the cell to attach.
Firstly, fibronectin working solution was prepared by diluting the stock solution into
50 mg/mL.
Then, a wet chamber was prepared using a 15 mm dish with parafilm placing on the
bottom and wet paper towels on the side. 200 µL fibronectin drops were added on the
parafilm sheet.
Finally, the PAAm gels were face down on the fibronectin solution drops and
incubated overnight at 4 ᵒC or 5 hr at room temperature.
5) Seed cell on coated PAAm gel surface. After surface conjugation of fibronectin, the
hydrogels were rinsed three times with sterile PBS under bio-hood and followed by UV
exposure for 30 min.
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Figure 3-4: Schematic illustration of the sandwich gel assembly process. (i) Activation of glass
surfaces with NaOH, 3-APTMS and glutaraldehyde. (ii) Polyacrylamide gel polymerization on the
top of the activated glass. (iii) Conjugation of sulfo-SANPAH on the surface of the polyacrylamide
gel by exposing gel surfaces to UV light, allowing the photoactivatable nitrophenyl azide group to
bond with the polyacrylamide. (iv) Finally, the NHS ester (N-hydroxysuccinimide) group in sulfoSANPAH is able to bond with the future ECM proteins like fibronectins or collagens, which is
essential for cells (green) to be able to adhere to the polyacrylamide surface (v). (Reproduced with
permission from Ref. [44], step vi will be excluded from our study)
Preparation, dispersion, and characterization of MWCNTs
MWCNTs were used for toxicity study. The MWCNTs solution was prepared as previously
reported.48 Briefly, 1 mg of MWCNTs was dispersed in 1 mL of phosphate buffered saline (PBS;
Life Technologies, Carlsbad, CA, USA) containing 5 mg of bovine serum albumin (BSA; SigmaAldrich, St. Louis, MO, USA) by slightly sonicating in a biological safety hood. The MWCNTs
stock solution was stored at 4 °C for long term use. When added to the cells, the MWCNTs was
further diluted in the culture medium to obtain the desired concentrations (0.06–0.6 μg/cm2) before
use. The in vitro CNT exposure doses were determined based on in vivo CNT exposure data
normalized to the alveolar surface area in mice. Previously, the in vitro surface area dose of CNTs
used was of 0.08−0.16 μg/cm2, relevant to in vivo exposure doses of 40–80 μg/mouse.49 In this
study, the doses of 0.06−0.6 μg/cm2 were chosen to cover the aforementioned range.
The length (L) and width (W) of individual dry CNT were 8.19 ± 1.7 μm (L) and 81 ± 5
nm (W). The size of MWCNTs was measured by using AFM. AFM measurement was performed
in tapping mode using a Veeco NanoScope MultiMode scanning probe microscope under ambient
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conditions. Topography images were recorded at the fundamental resonance frequency of the
cantilever, with a typical scan rate of 1 Hz and a resolution of 512 samples per line.
Production of collagen I was assessed by incubating the cells with MWCNTs at different
doses for 72 h on TCPS surfaces as well as PAAm gel surfaces followed by western blot analysis.
Previous studies showed that MWCNTs at high doses (≥ 0.6 μg/cm2) caused severe cytotoxicity.49
Because of the dose-dependent collagen I production, the dose of 0.2 µg/cm2 was chosen for
assessment of the substrate stiffness mediated fibrogenic response of the fibroblasts to
MWCNTs.50
Primary cell culture
NHLFs were used as our model for cell study due to the fact that lung fibroblasts are a
representative cell type that presents in the lung interstitium, which is considered to be associated
with collagen production during fibrogenesis.20, 32, 51 NHLFs were cultured in fibroblast basal
medium (FBM) supplemented with 2% FBS, 0.1% recombinant human fibroblast growth factor
basic (rhFGF-B), 0.1% insulin, 0.1% gentamicin/amphotericin-B (Lonza, Walkersville, MD,
USA), 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were used between passages 3-6.
Characterization of cellular response
Cell proliferation, immunofluorescent staining, and western blotting were used to conduct
various experiments to examine the cellular response of NHLFs to substrate stiffness.
Cell viability. Cell viability on PAAm gel with two different stiffness, 3 kPa and 100 kPa,
as well as on TCPS was evaluated by using CellTiter 96® AQueous One Solution Cell Proliferation
Assay. The data on TCPS was used as a control. NHLFs were seeded on PAAm gels (3 kPa and
100 kPa) that were made on 8 mm coverglass, which could fit into 48-well plate. Cells seeded
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directly on TCPS in 48-well plate were used as a control. For each group, three parallel samples
were prepared. Cells were allowed overnight to fully attach to the substrate. MWCNTs with a
concentration of 0.2 µg/cm2 were added on the following day and incubated with the cells. After
72 h of incubation, cell viability assay was performed by using CellTiter 96® AQueous One Solution
Cell Proliferation kit according to the manufacturer protocol. Briefly, the PAAm gels with cells
were transferred to a new 48-well plate and the cell proliferation kit reagent, CellTiter 96®
AQueous One Solution Reagent, was diluted in fibroblasts growth media by a concentration of 1:5
and added to the new plate. For TCPS samples, the original media was replaced by the same
amount of cell proliferation reagent. The 48-well plates were then incubated for an additional 4 h
at 37 °C. After 4 hours of incubation, 200 µL solution was sucked out from each well and added
to a 96-well plate. The absorbance of each well at a wavelength of 490 nm was measured by means
of an FLUOstar OPTIMA Microplate Reader (BMG LABTECH, Cary, NC, USA). The culture
medium containing the reagent was set as background.
Immunofluorescent staining. NHLFs on 3 kPa, 100 kPa PAAm gel as well as on TCPS
substrates were fixed with 4% PFA for 30 min at room temperature, permeabilized with PBS
containing 0.2% Triton-X 100 for 20 min at room temperature, and blocked using a PBS solution
containing 0.03 g/mL BSA, 1% goat serum (Sigma-Aldrich), and 0.2% Triton-X 100 for 1 h.
Primary antibody was conjugated in PBS solution with 0.2% Triton-X 100 for 2 h in ambient
condition. The samples were then washed with PBS solution containing 0.2% Triton-X 100 for
three times, 5 min for each wash. After the completion of washing, the secondary antibody was
conjugated in the same solution for 1h in dark at room temperature. F-actin was stained with Alexa
Fluor 488 phalloidin (Life Technologies), alpha-smooth muscle actin (α-SMA) was stained with
anti-α-SMA mouse polyclonal antibody (Abcam) and the nuclei were counterstained and mounted
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using ProLong Gold Antifade Reagent with DAPI. The fluorescent images were taken by using a
Nikon Ti Eclipse Fluorescence Microscope. The confocal images were taken by using Zeiss Violet
Confocal Microscope. 3D deconvolution was processed by using Imaris (Bitplane USA, Concord,
MA).
Reactive oxygen species (ROS) staining. NHLFs were seeded on the 3 kPa PAAm gel
substrates at a density of 15000 cells per cm2 and 100 kPa PAAm gel substrates at a density of
10000 cells per cm2. Cells cultured on TCPS at a density of 7500 cells per cm2 were set as the
control. Cells were cultured and allowed fully attached overnight and treated with 0.2 μg/cm2
MWCNTs on the following day. Cells were then incubated with MWCNTs for another 16 h. The
culture medium was then replaced with 1 mL Hank's balanced salt solution (HBSS) containing 10
μM dichlorodihydrofluorescein diacetate (DCFDA) and incubated for an additional 30 min. The
cells were finally fixed using 4% PFA solution and the nuclei were visualized using ProLong Gold
Antifade Reagent with DAPI. At least 10 images for each group were taken under the Nikon Ti
Eclipse fluorescence microscope with the same setting. The fluorescence intensities of images
were analyzed by using ImageJ and the ROS production per cell was calculated by subtracting the
background fluorescence intensity from Image fluorescence intensity, then divided by cell number.
Western blot. The western blotting assay was performed as previously reported.52 Passage
3 NHLFs were seeded on the 3 kPa PAAm gel substrates at a density of 15000 cells per cm2 and
100 kPa PAAm gel substrates at a density of 10000 cells per cm2. Cells cultured on TCPS at a
density of 7500 cells per cm2 were set as the control. Cells were cultured and allowed fully attached
overnight and treated with 0.2 μg/cm2 MWCNTs on the following day. After incubation with
MWCNTs for 72 h, the whole cell protein was extracted by lysing cells with radioimmune
precipitation assay (RIPA) buffer (Santa Cruz Biotechnology, CA, USA) containing protease and
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phosphatase inhibitors for 30 min on ice. The cell protein was then separated by 10% sodium
dodecyl

sulfate-polyacrylamide

gel

electrophoresis

(SDS-PAGE)

and

transferred

to

polyvinylidene difluoride (PVDF) membranes (EMD Millipore, Darmstadt, Germany). The PVDF
membranes were then blocked with 5% nonfat milk in 1× Tris-buffered saline with 0.1% Tween20 (TBST), followed by blotting with primary antibodies at 4 °C overnight with shaking, and
incubating with a horseradish peroxidase-conjugated secondary antibody (Sigma-Aldrich) for 1 h
at room temperature. Protein bands were visualized using enhanced chemiluminescence detection
reagents (EMD Millipore) and acquired by using a C DiGit Blot Scanner (LI-COR Biosciences,
Lincoln, NE, USA). The immunoblotting acquired was then analyzed by using ImageJ software
(https://imagej.nih.gov/ij/).
Rho-associated Protein Kinase (ROCK) inhibitor Y27632 treatment
Y27632, a specific drug to inhibit ROCK pathway was used to inhibit Rho kinase without
changing other kinase pathways.53, 54 After cells were seeded and attached overnight, Y27632 was
added on the following day 2 hours before MWCNTs treatment. The desired concentration was
achieved by diluting the stock 10 mM Y27632 solution with fibroblast complete growth media.
See Table 2 for the predefined concentration used in the experiment. Observation of the cells using
bright field microscope to see if there are any morphology changes after Y27632 has been added.
See supporting information for the bright field images taken to record the daily changes of the cell
morphologies.
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Table 3-2: The administrative dosage adding pattern for Y27632 treatment.
Total dosage

10 µM

Day 1

3 µM

5 µM

Day 2

3 µM

5 µM

Day 3

4 µM

16 µM
10 µM

8 µM
8 µM

Statistical analysis
The data will be presented as mean  standard error of mean (S.E.M.). Student’s t-test will
be used to determine the statistical difference. The proliferation (n = 3), collagen I expression (n =
3) and ROS generation (n > 10) of NHLFs were measured from three independent replicates for
each condition. Statistically significant differences will be considered at a level of p < 0.05.
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Results and Discussion
Cell morphology
Cell morphologies on 3 kPa, 100 kPa PAAm gel as well as on TCPS were examined first
under bright field. The phase contrast images were shown on the top row in Figure 3-5. Fibroblasts
displayed different morphologies as the substrate stiffness changed. The majority of the cells on
soft substrate (3 kPa) remained round shape without spreading out, indicating a weak cell-substrate
interaction. Cells on the stiff substrate (100 kPa) were similar to that on TCPS, which were
elongated and stretched out mostly.
Immunofluorescent staining of F-actin was also performed to visualize the actin fibers and
the cell morphology difference between 3 kPa, 100 kPa PAAm gels and TCPS. The fluorescent
images were shown on the bottom row in Figure 3-5. Similar to what was observed in the bright
field, cells on soft substrate (3 kPa) remained round shape without spreading out and there was no
obvious actin fiber that has been seen; cells on 100 kPa PAAm gel as well on TCPS were largely
stretched out and elongated, with more visible actin fibers.
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Figure 3-5: Cell morphologies of NHLFs on different PAAm gel substrates (3 kPa, 100 kPa) and
TCPS. Top row: phase contrast images of NHLFs cell morphologies on different PAAm gel
substrates. The scale bars are 400 µm. Bottom row: fluorescent images of fibroblasts cell
morphologies on different PAAm gel substrates. The F-actin (green) was immunostained with
Alexa Fluor 488® phalloidin and the nuclei (blue) were stained with DAPI. The scale bars are 50
µm.
CNT dosages determination
To further determine the dosage of MWCNTs, cell proliferation assay on TCPS with
various MWCNTs dosages was performed, with different incubation length from 1 day to 4 days.
The results of cell proliferation assay on TCPS with various MWCNTs dosages are shown in
Figure 3-6. Cells cultured without adding MWCNTs were used as a control. The reason of this
experiment was to give an idea on the choice of different MWCNTs dosage as well as the culture
length. We found that on day 3, the CNT group with 0.06 µg/cm2 and 0.2 µg/cm2 both showed a
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significant increase in cell proliferation, while for a higher dosage of 0.6 µg/cm2, the proliferation
started to decline at day 3, and further decreased on day 4 culture. This result was consistent with
the previous report that MWCNTs showed toxicity to the cells at a higher dosage doses (≥ 0.6
μg/cm2).49

Figure 3-6: Determination of MWCNTs dosage by cell proliferation assay on TCPS. The cells
were treated with MWCNTs at a dosage of 0.06 μg/cm2, 0.2 μg/cm2 and 0.6 μg/cm2. Cells treated
without MWCNTs were used as a control. Cells treated with different dosages of MWCNTs were
incubated for 4 days. Proliferation data was obtained every 24 h. *: significant difference (p <
0.05) from the control.
According to previous study,52 a dose of 0.2 μg/cm2 was hence chosen for establishing the
in vitro model of cell sensing nanomaterials. As shown in Figure 3-7, compared to 0.06 μg/cm2,
adding 0.2 μg/cm2 MWCNTs could induce more collagen production although these two dosages
showed similar proliferation after 72 h of incubation. Meanwhile, since MWCNTs showed toxicity
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to the cells at a higher dosage doses (≥ 0.6 μg/cm2), 0.2 μg/cm2 was finally chosen for assessment
of substrate stiffness regulated the fibrogenic response of NHLFs to MWCNTs.

Figure 3-7: Dose-dependent collagen production of fibroblasts treated with MWCNTs. (A)
Immunoblotting of collagen I. β-actin was used as the loading control. Fibroblasts were treated
with MWCNTs at different dosages of 0.06, 0.2 and 0.6 μg/cm2 for 48 h. (B) Densitometric
analysis of collagen I production based on the results of the immunoblotting in (A). (Adapted with
permission from Ref. [52])
CNT effects on cytoskeleton structure and nuclei
We further examined the cell cytoskeleton structure by performing immunofluorescent
staining of F-actin and α-SMA. F-actin was stained to demonstrate the presence of actin stress
fibers in NHLFs in order to visualize the cytoskeleton structure. α-SMA is a commonly used
molecular marker that has been found expressed by myofibroblasts, which is highly associated
with the lung fibrosis.55, 56 An important hallmark during fibrogenesis is the differentiation of
fibroblasts to myofibroblasts.57
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F-actin was immunostained with Alexa Fluor 488® phalloidin, which is a high-affinity Factin probe. α-SMA was stained with anti-α-SMA mouse polyclonal antibody. The confocal
images were shown in Figure 3-8. Corresponding to the previous cell morphology results,
fibroblasts exhibited different morphologies as the substrate stiffness changed. Cells on 3 kPa
remained compact morphologies with no visible stress fiber. On the contrary, cells on 100 kPa
substrate were elongated and stretched out with stress fiber formation. The stress fiber formation
became more obvious on TCPS substrates, suggesting that the expression of F-actin increased
when increasing the substrate stiffness. The stiffer the substrate was, the more expression of Factin.
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Figure 3-8: Immunofluorescent staining of F-actin, α-SMA and nuclei of NHLFs on different
substrates: 3 kPa, 100 kPa and TCPS. The last column on the right highlights the nuclei of the cells
cultured on TCPS. Top row: cells treated without MWCNTs were used as controls. Second row:
cells treated with 0.2 μg/cm2 MWCNTs. Third row: bright field images of the second row. The
arrows point to the MWCNTs localization inside the cells. The F-actin (green) was immunostained
with Alexa Fluor 488® phalloidin, the α-SMA (red) was stained with anti-α-SMA mouse
polyclonal antibody and the nuclei (blue) were stained with DAPI. The scale bars are 20 μm.
The influence of MWCNTs to cytoskeleton structure was revealed in Figure 3-8 with a
combination of the second and the third row. The CNTs structures could be seen clearly in the
bright field images and it was observed that when MWCNTs were present, the actin fiber was
distorted or disrupted, as well as the nuclei structure shown in the last column. Without MWCNTs,
the actin fiber was continuous and intact and the nuclei structure was in oval shape and smooth.
The detailed explanation for this phenomenon is still unclear and is open to investigation.
However, several studies have been done which revealed that CNTs or functionalized CNTs
possessed the ability to penetrate cell membranes and reach the nucleus of cancer cells.58, 59, 60, 61
It still remains to be elucidated that how CNTs translocate across the cell membrane. One of the
studies proposed that the translocation mechanism of CNTs was comparable to cell penetrating
peptides (CPPs), where they were able to reach nuclei due to their positive charge and the nuclear
localization signal conveyed by the amino acid sequences.60 It seemed from our results that
substrate stiffness could also be responsible for the CNTs uptake mechanism inside the cells (see
Figure 3-9). Compared to TCPS substrate, the nuclei of cells cultured on soft PAAm gel substrate
were less disrupted. However, solid evidence and more investigation are needed to explain this
observation.
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Figure 3-9: MWCNTs effects on nuclei. The first column shows the immunofluorescent staining
of F-actin (green), α-SMA (red) and nuclei (blue) of NHLFs on different substrates: 3 kPa, 100
kPa and TCPS. The second column shows the single channel of nuclei. The insets are the 3D
deconvolution of nuclei. The last column on the right shows the overlay images of the nuclei and
the bright field. The scale bars are 20 µm.
Fibrogenesis response
Cell Viability. Previous study has shown that increased cell proliferation is one of the
hallmarks of lung fibrosis,20 which was first investigated in the study to evaluate the fibrogenesis
response of NHLFs to MWCNTs on substrates with different stiffness. The results of cell viability
assay on 3 kPa and 100 kPa PAAm gel substrates as well as on TCPS with an MWCNTs dosage
of 0.2 µg/cm2 were shown in Figure 3-10.
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Figure 3-10: Cell viability of NHLFs on different PAAm gel substrates and TCPS control. The
cells were treated with MWCNTs for 72 h (labeled as MWCNTs in the plot). Cells treated without
MWCNTs were used as controls (labeled as CTRL in the plot). *: significant difference (p < 0.05)
from the TCPS controls; +: significant difference (p < 0.05) between groups.
As shown in Figure 3-10, cell number increased when stiffness increased, indicating that
on stiffer substrate, cell proliferation was more active than that on soft substrate. To compare the
MWCNTs effects within group, there was no significant increase on soft substrate (3 kPa) while
on 100 kPa gel substrate and TCPS, cell number was significantly increased, suggesting that
MWCNTs could enhance proliferation in a stiffness-dependent manner. Moreover, according to
the p-value from T-test, although on 100 kPa and TCPS, cell proliferation both showed a
significant increase, it increased much more on 100 kPa (p = 0.003) compared to that on TCPS (p
= 0.020). This phenomenon was agreed with a previous finding suggesting that soft substrate has
a much lower membrane tension compared to the stiff substrate, where the high membrane tension
of the cells on TCPS makes it hard for nanoparticles to enter, resulting in a higher cellular uptake
of nanoparticles on the soft substrate.62 This could be a possible explanation for the difference in
enhancement of CNTs on 100 kPa and TCPS. However, our results showed that cell proliferation
on the softest substrate (3 kPa) did not result in a noticeable increase, which may seem
contradictive to the previous theory. This could possibly result from the limited spreading area that
cells remain on the soft substrate. Previous results showed a rounded morphology of fibroblasts
that cultured on 3 kPa PAAm gel, whereas cells cultured on 100 kPa PAAm gel and TCPS
substrates were more spread and elongated. It has been also studied that when the cell area was
substantially decreased compared to the larger spreading area on two stiffer substrates, cellular
uptake of nanoparticles resulted in a much lower total amount.62
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Collagen I Expression. Western blotting was used to qualitatively and quantitatively
measure the collagen I production with or without adding MWCNTs. Figure 3-11 here showed the
western blot result of collagen I protein band and quantitative analysis.

Figure 3-11: Collagen I expression of NHLFs treated with or without 0.2 µg/cm2 MWCNTs. (A)
Immunoblotting of collagen I on 3 kPa, 100 kPa PAAm gel substrates as well as on TCPS. Tubulin
was used as the loading control. Fibroblasts were treated with MWCNTs for 72 h in positive group
(labeled as MWCNTs in the plot). Cells treated without MWCNTs were used as controls (labeled
as CTRL in the plot). (B) Densitometric analysis of collagen I expression based on the results of
immunoblotting in (A). *: significant difference (p < 0.05) compared to the TCPS controls.
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The collagen I production of fibroblasts on 3 kPa and 100 kPa was much lower than that
on TCPS, indicating that the expression of collagen depended on the stiffness of substrates. The
expression on 3 kPa substrates was significantly lower than TCPS with or without CNT treatment,
while on 100 kPa substrates it was less significant.
Other than cell proliferation, excessive deposition of collagen matrix was also considered
as a hallmark in lung fibrosis.63 Previous study has shown that collagen I production could be
significantly increased by dispersed SWCNT and MWCNT both in vivo and in vitro.64 From our
results, collagen I production was enhanced on all substrates with the presence of MWCNTs but
not significantly. It is speculated that this insignificant influence of MWCNTs was due to the
competing effects between CNTs induced collagen I production and the disruption of cytoskeleton
structure by CNTs. Previous studies have shown that CNT could induce lung fibroblasts
differentiation to myofibroblasts both in vivo and in vitro.22, 48, 65 The presence of myofibroblast
would result in synthesizing and secreting the ECM, which will increase the collagen I
production.57,
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From another perspective, our previous observation of immunofluorescent

staining in Figure 3-8 showed that the cytoskeleton structure seemed to disrupted when treated
with CNTs, along with the decreasing of α-SMA expression (red), which was a competitive effect
compared to CNTs induced myofibroblast differentiation because α-SMA was a commonly used
molecular marker indicating the formation of myofibroblast. The collagen I production under this
circumstance was expected to decrease. In the view of these two contradictory effects, the
significant of CNTs induced collagen production was compromised. However, this was not a
conclusive result where more solid evidence regarding the cytoskeleton organization was needed
to consolidate our finding.
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ROS Generation. Previous studies have shown that oxidative stress was associated with
the toxicity of the nanoparticles, hence played an important role in nanomaterial-induced
fibrogenesis.48, 67, 68 Lung tissue is generally exposed to more oxygen, which potentially leads it to
a more vulnerable condition of experiencing oxidative stress.69 MWCNTs could enter lung
interstitial via inhalation, where the deposition of nanoparticles could have the potential to generate
oxidative stress, thus triggering fibrogenic response. Therefore, the influence of substrate stiffness
on ROS generation in response to MWCNTs has been examined.

Figure 3-12: The influence of ROS generation of NHLFs on substrate stiffness in response to
MWCNTs. The NHLFs were treated with MWCNT for 16 h (labeled as MWCNTs in the plot).
Cells treated without MWCNTs were used as controls (labeled as CTRL in the plot). ROS was
stained with DCF-DA and nuclei were stained with DAPI. Quantitative ROS image analysis was
obtained from at least ten separate fields. *: significant difference (p < 0.05) compared to the TCPS
controls. +: significant difference (p < 0.05) between groups.
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As shown in Figure 3-12, the quantitative analysis of ROS generation suggested that as the
stiffness increased, the ROS generation increased with or without CNTs exposure, suggesting that
substrate stiffness could regulate ROS generation of NHLFs. The effects of MWCNTs treatment
resulted in enhanced ROS generation on all substrates. The level of increase was different between
these three substrates, which was correlated with the previous cell proliferation results. The
increase was not obvious and no significance on the soft substrate (3 kPa) whereas significant
increases were both observed on 100 kPa PAAm substrate and TCPS.
Although extensive studies have been done that suggested the CNTs induced substantial
ROS production, less effort has been made to explore the stiffness mediated ROS generation when
exposed to CNTs. One studies used MSCs as a model cell to investigated the stiffness affected
ROS generation by using PAAm gel substrate in kilopascal range compared to the fibronectincoated glass surface in gigapascal range, which revealed that ROS generation on the soft substrate
was increased by a 2-4 fold when remained noncytotoxic.70 The result was not agreed with our
findings possibly due to the difference in cell model and the different in vivo condition. Our result
indicating that fibroblasts endured more oxidative stress when cultured on stiffer substrates (100
kPa), which represented the fibrotic lung tissue. On the contrary, on soft substrate (3 kPa), normal
lung tissue was under lower oxidative stress. This result highlighted the importance of
incorporating stiffness cue to build a physiologically relevant model to investigate cell behavior
for disease model.
Mechanosensing
Influence of stiffness on focal adhesion kinase (FAK) and phosphorylated tyrosine397 FAK (pFAK). FAs are dynamic protein molecules that regulate signals reflecting how cells
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respond to ECM, serving as a link between cytoskeleton and ECM.71, 72, 73 FAK is a key signaling
kinase in FAs which could respond to substrate stiffness, thus mediate mechanotransduction.74
Western blotting was performed to examine the total and activated FAK levels by using antibodies
specific for FAK and pFAK.

Figure 3-13: Protein expression of NHLFs treated with or without 0.2 µg/cm2 MWCNTs. (A)
Immunoblotting of F-actin, α-SMA, FAK and pFAK on 3 kPa, 100 kPa PAAm gel substrates as
well as on TCPS. Tubulin was used as the loading control. Fibroblasts were treated with MWCNTs
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for 72 h in positive group. (labeled as MWCNTs in the plot). Cells treated without MWCNTs were
used as controls (labeled as CTRL in the plot). (B) Densitometric analysis of the protein level of
F-actin, α-SMA, FAK and pFAK based on the immunoblotting results of (A). *: significant
difference (p < 0.05) compared to the TCPS controls.
Generally speaking, the stiffness effects of all four proteins were significant on 3kPa
PAAm gel while the CNTs effects on the protein expression didn’t show significant influence.
From the immunoblotting in Figure 3-13A, both FAK and pFAK showed a similar trend of
increased level when increasing the substrate stiffness. Quantitative analysis of the protein bands
in Figure 3-13B showed that compared to TCPS controls, both the protein level of FAK and pFAK
showed significantly decreased expression on soft substrate (3 kPa) regardless of whether under
CNTs treatment. The effects of CNTs on the expression of FAK was highly stiffness-dependent.
On soft substrate (3 kPa), the CNTs significantly increased the FAK expression, whereas on 100
kPa gel substrate and TCPS, FAK expression showed slightly increase and decrease, respectively.
For pFAK, CNTs induced expression on all three substrates while none of which was significant.
Influence of stiffness on F-actin and α-SMA. One of the important characters of lung
fibrosis is the differentiation of lung fibroblasts into myofibroblasts which synthesize and secret
the ECM.57, 66 Fibroblasts in normal tissue exhibit little ECM production whereas in damaged
tissue, they actively migrated towards the injured tissue and began to produce ECM.56, 75 We thus
investigated the F-actin expression and also α-SMA expression, a molecular expressed by
myofibroblasts to identify the influence of substrate stiffness affected cell sensing CNTs.
As shown in Figure 3-13A, cells on soft substrate (3 kPa) generally expressed little F-actin
as well as α-SMA. The soft substrate is comparable to normal lung tissue stiffness in vivo. When
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the stiffness increase to 100 kPa and as well as on TCPS, the expression of F-actin and α-SMA
were augmented. It has been suggested that fibroblasts could form contractile stress fibers when
activated by stiffer substrate because matrix mechanical change caused constant change of ECM
remodeling. from, whereas little to no stress fibers were formed on soft substrate.56, 65, 76 From the
quantitative analysis shown in Figure 3-13B, the CNTs effects on F-actin formation was not clearly
shown on softer substrate (3 kPa and 100 kPa). The increase on TCPS induced by CNTs was not
significant, either. Moreover, it was observed that when treated with CNTs, α-SMA expression
was significantly decreased on softer substrate (3 kPa and 100 kPa) compared to the TCPS control.
Effects of intracellular tension
Effects of intracellular tension on TCPS. To further understand how cells respond to
substrate stiffness in molecular level, we examined the effects of intracellular tension on
fibroblasts by inhibition of the Rho-ROCK signally pathway. RhoA is one of the most studied that
belongs to Rho family of GTPase, which is a family of small G proteins that involves in
intracellular signal transduction. Extensive studies have shown that RhoA could regulate the
remodeling of actin cytoskeleton, inducing stress fiber formation and upregulating the focal
adhesion formation.77 It has been reported that higher intracellular tension was observed on stiff
substrate, thus cells are more spreading and elongated, generating more stress fibers and where
they adversely exerted augment traction force on the substrate.77, 78, 79, 80 By inhibiting ROCK
signally pathway, which is activated by RhoA, we could further investigated the mechanism of
substrate stiffness modulated cellular response. Y27632, a pharmacological inhibitor of ROCK,
was used inhibit the ROCK signally pathway.
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To determine the proper dosage for Y27632, we first conducted the experiment on TCPS
by using several dosages of Y27632 and different administrative adding pattern (see Table 2). Cell
morphologies were taken under bright field as a record (see Figure 3-14).
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Figure 3-14: Bright field images of cells treated with different dosages of Y27632. NHLFs were
seeded on day 0. Y27632 was added from day 1 according to the predetermined dosages described
in Table 3-2.
Since the most commonly used dosage used for Y27632 is 10 µM54, 81, we chose 10 µM as
the primary targeting dosage. We overserved that when adding a total dosage of 10 µM, cells
experienced a distinct morphology change as they were being highly attenuated and elongated (see
Figure 3-15). While when adding 5 µM for each day for two days in a row, cells largely remained
as their original morphologies. In this view, (5 + 5) µM was chosen for the following stiffness
study. Moreover, fluorescent images showed that stress fibers were largely decreased when treated
with Y27632, while there were clear stress fibers present in the control group (no Y27632
treatment). This result agreed with the previous theory that Rho-ROCK signally pathway is
associated with stress fiber formation.
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Figure 3-15: Images of NHLFs cell morphologies treated with different dosages of Y27632. Cells
were cultured on TCPS. Fibroblasts were treated with MWCNTs for 72 h in positive group (labeled
as MWCNT in the figure). Cells treated without MWCNTs were used as controls (labeled as
CTRL). The F-actin (green) was immunostained with Alexa Fluor 488® phalloidin and the nuclei
(blue) were stained with DAPI. The bright field images represent MWCNTs localized in the cells.
The scale bars are 50 µm.
To further evaluate the effects of ROCK signaling in regard to different Y27632 dosages
treatment, western blotting was performed to examine the collagen I expression under various
Y27632 treatment. Figure 3-16 showed the immunoblotting and the quantitative analysis of
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collagen I expression, which indicated a downregulated mechanism of Y27632 to collagen I
expression regardless of the dosage. However, statistical analysis did not reveal a significant
decrease for either of the three dosages. Moreover, the treatment of MWCNTs didn’t result in a
significant increase in collagen expression. This observation was possibly related to the cell
morphology change when adding Y27632 and decreased cell spreading area. It was observed that
when treated with Y27632, cells were stretched and changed their morphologies in a dosedependent manner. When increased the dosage from 10 µM total to a (8 + 8) µM total, the
elongation and morphology change was increased, resulting in a decreased cell spreading area. For
a total of 10 µM, adding in one day caused more morphology change than adding 5 µM each day.
The reduced cell area compared to control could result in a decrease in cellular uptake of the
nanoparticle. However, inhibiting ROCK pathway by Y27632 would initially lower the
intracellular tension, and previous reports showed a upregulated uptake of nanoparticle with lower
membrane tension.62 According to Figure 3-16B, the collagen I production showed no significant
change after adding CNTs, it was speculated that it was because of a neutralization of the two
competing mechanisms.
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Figure 3-16: Collagen I expression of NHLFs exposed to 0.2 µg/cm2 MWCNTs when treated with
different dosages of Y27632 on TCPS. (A) Immunoblotting of collagen I treated with different
dosages of Y27632 TCPS. Tubulin was used as the loading control. Fibroblasts were treated with
MWCNTs for 72 h in positive group (labeled as MWCNTs in the plot). Cells treated without
MWCNTs were used as controls (labeled as CTRL in the plot). (B) Densitometric analysis of
collagen I expression based on the results of immunoblotting in (A).
Effects of intracellular tension on 100 kPa PAAm gel. Based on the immunofluorescent
results and western blotting performed on TCPS, we chose (5 + 5) µM for the following study of
intracellular tension effects on 100 kPa PAAm gel. Western blotting also performed to show the
collagen I expression when inhibiting ROCK on 100 kPa PAAm gel (see Figure 3-17). In contrary
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to the results obtained from TCPS, Y27632 exhibited an upregulated mechanism when cultured
on 100 kPa PAAm gel. Although the detailed explanation of this phenomena remained unclear and
needed to be further explored, we speculated that it might because culturing on soft gel (100 kPa
compared to TCPS) lowered the membrane tension, which favored the cellular uptake of
nanoparticles,62 thus increasing the collagen I production when treated with both Y27632 and
MWCNTs. The preliminary condition of this explanation based on the similar spreading area that
we observed before and after adding Y27632 on 100 kPa PAAm gel (see Figure 3-17B).

Figure 3-17: Collagen I expression of NHLFs exposed to 0.2 µg/cm2 MWCNTs and (5 + 5) µM
Y27632 on 100 kPa PAAm gel substrates. (A) Immunoblotting of collagen I treated with (5 + 5)
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µM Y27632. Tubulin was used as the loading control. Fibroblasts were treated with MWCNTs for
72 h in positive group (labeled as MWCNTs in the plot). Cells treated without MWCNTs were
used as controls (labeled as CTRL in the plot). (B) Comparison of cell morphologies before and
after adding Y27632. The scale bars are 200 µm.
We further conducted the same experiment by changing the substrate material to PDMS
(see Figure 3-18) while remaining the same substrate stiffness. PDMS with a 100 kPa stiffness
was obtained by varying the ratio of the base material and curing agent (30:1) as well as controlling
the curing condition.82, 83, 84
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Figure 3-18: Collagen I expression of NHLFs exposed to 0.2 µg/cm2 MWCNTs and (5 + 5) µM
Y27632 on 100 kPa PDMS gel substrates. (A) Immunoblotting of collagen I treated with (5 + 5)
µM Y27632. Tubulin was used as the loading control. Fibroblasts were treated with MWCNTs for
72 h in positive group (labeled as MWCNTs in the plot). Cells treated without MWCNTs were
used as controls (labeled as CTRL in the plot). (B) Densitometric analysis of collagen I expression
based on the results of immunoblotting in (A).
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From the immunoblotting, we could see that the collagen I expression under different
condition showed no obvious change either treated with Y27632 or MWCNTs. The different result
obtained from PDMS compared to previous PAAm result was possibly due to the structural
difference between PDMS and PAAm, although they were designed for the same stiffness. One
study has shown that cell responses to the substrate stiffness were not from the bulk stiffness but
the coated ECM anchor point.85 The structure of PAAm is porous, where the pore size is associated
with stiffness. Even under the same bulk stiffness, PDMS didn’t have the porous structure, which
might result in difference in cell behavior.
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Conclusion
There has been evolving and compelling evidence showed that substrate stiffness could
have a profound influence on cell behavior including cell adhesion, cell spreading, cell migration,
cell proliferation and cell migration. More and more studies have been done to realize the important
roles that substrate stiffness played in regulating cell behavior. This study systematically
investigated cellular responses to CNTs by incorporating stiffness cue to replicate the
physiological condition of the human body. PAAm gel substrates were fabricated to represent
normal human lung tissue and fibrotic lung tissue, respectively. NHLFs were cultured on PAAm
substrates with different stiffness as well as on TCPS. Our findings indicated that substrate
stiffness played a significant role in regulating cell phenotype and function, including cell
adhesion, cell spreading, cell elongation and cell proliferation.
NHLFs on soft (3 kPa) substrates were rounded without actin fibers, on the contrary, cells
on stiffer (100 kPa) substrates and TCPS were largely elongated with visible stress fibers. The
fibrogenesis response of the cell to MWCNTs could also be mediated by substrate stiffness,
including the increased collagen I expression, cell proliferation and ROS generation. Moreover,
we found out that CNTs did induce the production of collagen I but not significant. The CNTs
effects on cell proliferation and ROS generation were highly dependent on the substrate stiffness,
where they didn’t induce significant increase on soft substrates, but the increases in cell
proliferation and ROS generation were both significant on 100 kPa substrates and TCPS.
Furthermore, results of the mechanosensing showed similar trends on stiffness modulated the
protein level expression of F-actin, α-SMA, FAK expression. Finally, by inhibiting the Rho-ROCK
signally pathway, we were trying to understand the substrate stiffness affected cellular responses
to CNTs down to molecular level. We found out that ROCK pathway was associated with the
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collagen I synthesis and the CNTs induced collagen I effect was compromised by inhibiting
ROCK. However, there are still needs to explore the mechanism of substrate stiffness effect.
This study provides a basic understanding of stiffness modulated cell behaviors and could
potentially serve as an in vitro platform for disease modeling. While nanotechnology has been
widely used in a diversity of different applications, the increasing concern of the toxicity of
nanomaterials has been brought to attention. Efforts have been made to address the issues
regarding the toxicity study of nanomaterials, while most of the established in vitro models were
based on using stiff TCPS where the stiffness is far from most of the tissues existing in the human
body. The novelty of our study was to build a physiologically relevant in vitro model by
introducing stiffness cue to mimic the microenvironment of normal and fibrotic lung tissue for
disease toxicology study of cellular response to MWCNTs, where there have been few reports on
the idea of studying the toxicity by varying the substrate stiffness. We systematically investigated
the substrate stiffness affected cell behaviors, as well as the fibrogenesis response of cellular
responses to CNTs. Also, we targeted the cellular responses to CNTs through mechanosensing and
intracellular tension, which helped further understanding the mechanism of substrate stiffness
modulation of cell behaviors.
The stiffness cue could also be further applied to three-dimensional culture model to largely
replicate the actual in vivo condition. Ultimately, the in vitro platform for disease modeling could
be further optimized by introducing flow and shear stress to mimic the dynamic in vivo
microenvironment into microfluidic devices. For example, simulating the breathing condition of
the lung in the “lung-on-a-chip” could be potentially used as a reliable disease model for
understanding and studying lung fibrosis.
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Chapter 4: Path Forward
From the perspective of understanding the mechanism of the human disease and achieving
ultimate treatment, it is of great significance to build in vitro disease model that could largely
represent the actual in vivo condition. Although numerous experiments and researches have been
done using animal models, there are still gaps existing between the results obtained from animal
and human, causing the barrier to disease detection and drug development. In this dissertation, our
work emphasized incorporating two biophysical cues, nanotopography cue and stiffness cue, into
the process of disease detection and in vitro disease modeling, which had the potential to mimic
the in vivo microenvironment. Both studies were basic research to understand the two biophysical
cues, which eventually should be optimized and integrated into a platform for disease detection,
diagnosis and treatment.
Incorporating nanotopography into CTCs capture
For nanotopography cue, we used adhesion preference on nanotopographies with various
shapes and dimensions to capture tumor cells instead of culturing on flat substrate, which was
inspired by the tremendous nanoscale structures inside human tissue. Our study provides useful
information to optimize nanotopography to further improve tumor cells capture efficiency, which
plays a major role in early cancer detection and diagnosis. Based on what we obtained from our
results and the current research studies, there are multiple future aspects: optimization of shape
and dimensions of nanotopographies, surface chemistry modification, surface biomarker
conjugation, the use of artificial blood sample or patient blood sample and ultimately integration
of nanotopography into a microfluidic device.
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Optimization of shape and dimensions. Motivated by the present work, the first path
forward is going to be testing the different geometry and dimension of the nanotopography surface.
In our study, we fabricated the representative nanopillars and nanogratings with specific
dimensions to capture tumor cells. Results showed that the geometry did put an impact on the
capture efficiency, which made the next step further be optimizing the nanotopography to further
improve the cell adhesion, thus favored cell capture. Although nanogratings and nanopillars are
representative ones, they are not the optimized ones. The optimization could focus on increasing
cell-nanotopography interactions and facilitating focal adhesion formation. The previous reported
RIE generated nanoroughened surface could achieve a capture efficiency up to 95% within 1 hour
(see Figure 4-1).1 One of the reasons that such a high capture efficiency could be reached was the
nanoroughened, chaotic structure that has been generated by RIE that largely enhanced the celltopographical interactions. Another reason might need to be taken into consideration was that the
material they used was glass instead of PDMS in our study. PDMS is hydrophobic and typically
inert to cell adhesion, whereas glass is more hydrophilic. The material that is used to perform the
CTCs capture could also be carefully selected and modified.
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Figure 4-1: RIE generated nanoroughened surface for cancer cell capture. (A) The process of
generating nanotopography on glass surface by RIE. (B) Schematic of nanotopography fabricated
by RIE on glass surface compared to smooth surface and the cell capture performance on each
substrate, respectively. Enlarged views show cell captured on the illustrated nanotopography (left)
and SEM (right) micrographs of cancer cells captured on nanoroughened glass surfaces.
(Reproduced with permission from Ref. [1])
Surface chemistry. As previously mentioned RIE generated nanoroughened surfaces,
while it created a nanotopography surface to enhance the cell-topographical interaction, the RIE
treatment could also chemically activate the surface, thus favoring cell adhesion (see Figure 4-1).
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Surface biomarker conjugation. The next future direction could focus on shortening the
capture time by conjugating surface biomarkers on the nanotopography surfaces to capture specific
tumor cells. As shown in our results, the capture time used was 4 h, which was not fast enough to
capture or detect CTCs. However, the importance of early diagnosis has a substantial influence on
the disease treatment and patient survival. For example, statistics showed that the number of
survived women who diagnosed with breast cancer at the earliest stage is 6-fold compared to that
who diagnosed at the advanced stage.2 Based on our findings that 500-1x-150 nanogratings could
enhance the adhesion of tumor cells, thus enhanced the capture efficiency, it is possible to shorten
the capture time by chemically modifying the surface of the optimized nanogratings. Because, as
previously mentioned in Chapter 2, the most widely used CTC capture techniques rely on positive
selection based on surface biomarkers such as EpCAM expression on tumor cells.3 Besides
EpCAM, there are various surface markers that expressed by different types of CTCs, which has
been widely used for CTC isolation for cancer diagnosis.4 By identifying the specific biomarker
that expressed on CTC to justify the proper antibody that could be conjugated to the surface, the
capture efficiency is expected to be improved. By combining the topographical modulation and
the chemical modification, the capture time could expect to be shortened and the capture efficiency
is going to be further improved.
The use of artificial blood sample or patient blood sample and ultimately integration
of nanotopography into a microfluidic device. The next step would be testing our system by
using artificial blood sample, and ultimately, the optimized capture platform could be incorporated
into the microfluidic system to largely mimic the dynamic blood flow. In real in vivo condition,
CTCs are always circulating inside the bloodstream instead of static growing. The capture
efficiency that obtained from static culturing was still substantially deviating the actual condition.
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The flow rate, shear stress in the dynamic culture condition would potentially change the outcome
of the cancer cell capture and disease detection. Recently, a group reported a microfluidic CTC
capture chip by using nanoroughened glass substrate and achieve a significantly high capture yield
of CTCs from blood samples (see Figure 4-2).5

Figure 4-2: Nanoroughened surfaces incorporated microfluidic device for cancer cell capture. (a)
Image for the cancer cell capture microfluidic device. The enlarged views show the SEM
micrographs of the nanotopography surface (upper) and the cell captured on the nanotopography
(lower). (b) Quantitative measurement of capture efficiency of cell captured on nanotopography
compared with smooth substrates. The artificial blood sample was spiked with 1,000 cells for each
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cell type. **: significant difference (p < 0.01) between groups. (Adapted with permission from
Ref. [5])
Incorporating stiffness into disease modeling
For stiffness cue, we used both soft and stiff PAAm gel to represent normal and fibrotic
lung tissue, respectively, to understand how the matrix stiffness affects cell sensing nanomaterials.
Our findings suggested that substrate stiffness played an important role in modulating cell
behaviors and function, including cell elongation, proliferation, fibrogenic response and
mechanosensing, which established a basic understanding of how substrate stiffness affected cell
behavior, leading the next step to land on incorporating stiffness cue into three-dimensional culture
model, which advanced the current in vitro two-dimensional model and more closely mimic the in
vivo condition. As in in vivo microenvironment, cells are embedded in multiple ECM components
whereas in our model, cells were cultured on top of the substrate with various stiffness, which was
essentially a two-dimensional model. Technically speaking, the identification of whether cells are
cultured under two-dimensional or three-dimensional condition is based on how adhesion proteins
are formed, where under two-dimensional they are formed on the top of the cells and around the
cells from all 360 degrees under three-dimensional condition (see Figure 4-3).6
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Figure 4-3: The difference between 2D culture (collagen-coated glass) and 3D culture (collagen
gel) in regard to adhesion, polarity, spreading, matrix distribution and matrix stiffness. This
illustration shows that the parameters cell are faced with under these two culture conditions are
substantially different because of the dimensionality. (Adapted with permission from Ref. [6])
Currently, there have been more and more in vitro study that shifted their focus from
traditional two-dimensional culture to three-dimensional culture to better understand how cell
responses to the surrounding environment and the mechanical properties of the matrix.7 As cell
behavior could possibly be altered by the variation of cultural environment. For example, as our
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study suggested that when cultured on PAAm gel, the increase in substrate stiffness could enhance
cell elongation and spreading, where the results seemed counterintuitive while incorporating the
system into three-dimensional culture. A studied has shown that valvular interstitial cells (VICs)
encapsulated in soft gels expressed more actin fibers while in stiffened gels, there was no obvious
exhibition of α-SMA or F-actin fibers.7 This results confirmed what previously proposed that cell
behaviors could be affected and changed by the alteration of culture dimensionality.
Moreover, the future model establishment may combine both nanotopographical cue and
stiffness cue as they both serve important functions in the composition of the ECM. For example,
one study that incorporated both nanotopography cue and stiffness cue by embedded Calu-3 and
MDCK-II cells in Matrigel that was composed of important proteins existed in the ECM like
laminins, collagen IV, and entactins.8 The cells were cultured on fabricated nanograss substrates.
Results showed that this model could reflect the cell microenvironment as the cells formed tissuelike structures that were similar to their morphologies in vivo.9
Finally, the ultimate direction for our work would be the establishment of “organ-on-achip”, which incorporates everything into microfluidics to conduct three-dimensional dynamic
culturing. Although the current three-dimensional in vitro model has advanced applications in
closely replicating the in vivo microenvironment for disease study, it still has the intrinsic
limitation of being a static model. The ECM in the human body is a dynamic environment with
numerous substance and signal exchanges that happen all the time. Cells that are embedded into
three-dimensional culture model without external flow are normally lack of the mechanical cues
including the shear stress, physical force, tension,10, 11 which are crucial factors to the development
of tissue and organ when analyzing the disease model.12 In the perspective of introducing fluid and
to overcome the limitations of the current three-dimensional model, the recent development of
127

microfluidic-based organ-on-a-chip attracts substantial interests across the biomedical field
including disease detection and modeling as well as drug development,13, 14 including lung on a
chip,15, 16 kidney on a chip,17, 18 liver on a chip,19, 20 and body on a chip.21 Figure 4-4 here listed
several microfluidic chips that mimic the different organs in human body.22

Figure 4-4: “Organ-on-a-chip” microfluidic devices that were fabricated to mimic tissue
microenvironment for different disease models. (Reproduced with permission from Ref. [22]) (a)
Liver Chip: The liver-on-a-chip microfluidics device was designed to mimic the hepatic cords
structure in liver tissue. The cell culture area and the medium flow channel was divided by an
endothelial-like barrier. This specific design made it possible that the rat primary hepatocytes
formed a two line alignment which the formation of bile canaliculi along the hepatic cords-like
structure could be largely facilitated.19 (b) Kidney Chip: The kidney-on-a-chip microfluidics
device was designed to mimic the tubular microenvironment in vivo for primary rat inner
medullary collecting duct (IMCD) cells. This particular multi-layer microfluidics design
incorporated PDMS channel and a porous membrane which was able to introduce fluid flow for 5
hours.17 (c) Lung Chip: The lung-on-a-chip microfluidics device was designed to create a
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physiologically relevant model to mimic the alveolar system of human lung organ. The alveolarcapillary barrier was formed between two PDMS compartments on a porous membrane. This
specific bioinspired microdevice also had the capability of mimicking the breathing movement,
which had the potential application in nanotoxicity studies to test the lung inflammatory responses
to silica nanoparticles.15 (d) Body Chip: The body-on-a-chip microfluidics device was designed to
regenerate the in vivo microenvironment that reproduced organ-organ interactions. To achieve the
desired purpose, different types of cell lines representing the liver, tumor, and marrow were
embedded in the three-dimensional collagen hydrogel that was linked by the media flow of the
microchannel that mimicked the blood flow. The specific type of the design had great potential by
replicating organ-organ interactions, establishing a new platform for in vitro disease detection and
modeling in a more realistic, in vivo-like microenvironment.21
This research direction of incorporating nanotopographical cue and substrate stiffness cue
to build an organ-on-a-chip model should be based on optimizing the previous results for twodimensional study and three-dimensional static study, choosing the suitable conditions for threedimensional dynamic microfluidic study, which will ultimately provide great insight and useful
reference for disease detection and modeling. The “organ-on-a-chip” microdevices that integrated
biophysical cues could have the large potential of expanding the current cell culture in vitro models
and providing the feasible alternatives to lower the cost of expensive in vivo animal models.15
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